<SEC-DOCUMENT>0001104659-23-055056.txt : 20230502
<SEC-HEADER>0001104659-23-055056.hdr.sgml : 20230502
<ACCEPTANCE-DATETIME>20230502164543
ACCESSION NUMBER:		0001104659-23-055056
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230501
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230502
DATE AS OF CHANGE:		20230502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHPEAK PROPERTIES, INC.
		CENTRAL INDEX KEY:			0000765880
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		IRS NUMBER:				330091377
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08895
		FILM NUMBER:		23879920

	BUSINESS ADDRESS:	
		STREET 1:		5050 SOUTH SYRACUSE STREET
		STREET 2:		SUITE 800
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237
		BUSINESS PHONE:		949-407-0700

	MAIL ADDRESS:	
		STREET 1:		5050 SOUTH SYRACUSE STREET
		STREET 2:		SUITE 800
		CITY:			DENVER
		STATE:			CO
		ZIP:			80237

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCP, INC.
		DATE OF NAME CHANGE:	20070911

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTH CARE PROPERTY INVESTORS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2314172d4_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:hcp="http://hcpi.com/20230501">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_hcp_hcpi.com_20230501 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20230501_20230501 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000765880 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityCentralIndexKey">0000765880</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="hcp-20230501.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-01to2023-05-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000765880</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Washington</b></span><b>,
D.C. 20549</b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20230501__20230501_zLC3AV6lmnnj"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section&#160;13 or 15(d)&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of the Securities Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported) <span id="xdx_90E_edei--DocumentPeriodEndDate_c20230501__20230501_z8m7IgPVSIQe"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 1, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_900_edei--EntityRegistrantName_c20230501__20230501_z8fWajvJa7Ug"><b><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityRegistrantName">Healthpeak
Properties, Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact Name of Registrant as Specified in its
Charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-left: auto; margin-right: auto">
<tr style="vertical-align: top">
    <td style="text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20230501__20230501_zIZiNRoRkMda"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Maryland</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 34%"><span style="font-size: 10pt"><b><span id="xdx_909_edei--EntityFileNumber_c20230501__20230501_zdCP3JJaNXVj"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityFileNumber">001-08895</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 33%"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20230501__20230501_zsmEvQ4KN2Sh"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityTaxIdentificationNumber">33-0091377</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><b>(State or other Jurisdiction<br />
    of Incorporation)</b></td>
    <td style="text-align: center"><b>(Commission File Number)</b></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(I.R.S. Employer Identification No.)</b></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20230501__20230501_zjdg166Lcfu9"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressAddressLine1">4600 South Syracuse Street</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20230501__20230501_zojldswxONTl"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressAddressLine2">Suite 500</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20230501__20230501_zVOWdAM6y1Ze"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressCityOrTown">Denver</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20230501__20230501_z2WKAiMl76pf"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressStateOrProvince">CO</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20230501__20230501_zetwFPZhGsr6"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressPostalZipCode">80237</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of principal executive offices)
(Zip Code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_903_edei--CityAreaCode_c20230501__20230501_zxj4UbFPFkAk"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:CityAreaCode">720</ix:nonNumeric></span>) <span id="xdx_90C_edei--LocalPhoneNumber_c20230501__20230501_zbxpaO70NW5g"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:LocalPhoneNumber">428-5050</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant&#8217;s telephone number,
including area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former name or former address, if changed since last report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90E_edei--WrittenCommunications_c20230501__20230501_zHmTaBPz4Bs1"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule&#160;425
    under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_906_edei--SolicitingMaterial_c20230501__20230501_zRvHOjagvZMj"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule&#160;14a-12
    under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementTenderOffer_c20230501__20230501_z9wjWwZJYNDj"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to
    Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20230501__20230501_zdKbSIjK9Ar1"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications
    pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Trading symbol(s)</span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--Security12bTitle_c20230501__20230501_zhm08d8dhok8"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:Security12bTitle">Common stock, $1.00 par value</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--TradingSymbol_c20230501__20230501_zuYYWDaI2PEg"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:TradingSymbol">PEAK</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--SecurityExchangeName_c20230501__20230501_zwSMNkozOruk"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Emerging growth company</span> <span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20230501__20230501_z2xcVf2iehSd"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;1, 2023, Healthpeak
OP, LLC, a Maryland limited liability company (&#8220;Healthpeak OP&#8221;), and Healthpeak Properties,&#160;Inc., a Maryland corporation
(the &#8220;Company&#8221;), entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with the representatives
of the several underwriters named therein (the &#8220;Underwriters&#8221;) relating to the sale by Healthpeak OP (the &#8220;Offering&#8221;)
of $350.0 million aggregate principal amount of 5.250% senior unsecured notes due 2032 (the &#8220;Notes&#8221;). The Notes will be a
further issuance of, are interchangeable with and will be consolidated and form a single series with, the 5.250% senior unsecured notes
due 2032 of Healthpeak OP issued on January&#160;17, 2023 in the aggregate principal amount of $400.0 million. Upon the issuance of the
Notes, the outstanding aggregate principal amount of the 5.250% senior unsecured notes due 2032 will be $750.0 million. The Underwriting
Agreement contains customary representations, warranties, covenants and conditions. In the Underwriting Agreement, Healthpeak OP and the
Company agreed to indemnify the Underwriters against certain liabilities that could be incurred by them in connection with the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The estimated net proceeds
from the Offering are expected to be approximately $346.9 million, including approximately $5.8 million of accrued interest, after deducting
the underwriting discount and estimated expenses payable by Healthpeak OP. Healthpeak OP intends to use the net proceeds from the Offering
to repay borrowings outstanding under its commercial paper program and for general corporate purposes, which may include repaying or repurchasing
other indebtedness, working capital, acquisitions, development and redevelopment activities, and capital expenditures. The Offering is
expected to close on May&#160;10, 2023, subject to the satisfaction of customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing is a summary
description of certain terms of the Underwriting Agreement and is qualified in its entirety by reference to the Underwriting Agreement,
which is filed as Exhibit&#160;1.1 to this Current Report on Form&#160;8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The press release announcing
the pricing of the Offering is filed as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits. The following exhibits are being filed herewith:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 7%">
    <p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>No.</b></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 92%">
    <p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description</b></p></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2314172d4_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2314172d4_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated May&#160;1, 2023, by and among Healthpeak OP, the Company and the representatives of the Underwriters.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2314172d4_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2314172d4_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated May&#160;1, 2023.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HEALTHPEAK PROPERTIES,&#160;INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: May&#160;2, 2023</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <i>Peter A. Scott</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter A. Scott</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LXMdE3F3OlTEKTJEvK0uk+LWjLT+PZJvad0QQyAkJ985QgzEkha6RobjrMhhj01bK4dQYIWM5oz+I1utU/CzwIu2jpVx3foDM/IMemYUypO/d593bbFMQcphlAzlBKI4TcYw3Yjgq2dkKl2icVrVoEwJO6aWNTrFr95hr55kqHl1SQdkq8l4uzDq5TfEkYxhS3f1IL5ayPNMBIOuArFkurXfmJt11MC8xsZn2R79d/AB1gRJDA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2314172d4_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt; text-align: right"><B>Exhibit&#8239;1.1</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B><I>Execution Version</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">$350,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Healthpeak OP, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(a Maryland limited liability
company)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">guaranteed by</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Healthpeak Properties,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(a Maryland corporation)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5.250% Senior Notes Due 2032</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>UNDERWRITING AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><U>Page</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: right; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale and Delivery to Underwriters; Closing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covenants of the Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of Expenses</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions of the Underwriters&rsquo; Obligations</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contribution</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations, Warranties and Agreements to Survive
    Delivery</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;9.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;10.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Default by One or More of the Underwriters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;11.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Agreements of the Underwriters</FONT></TD>
    <TD STYLE="text-align: right">27</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;12.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;13.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;14.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing Law and Time</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;15.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognition of the U.S. Special Resolution Regimes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;16.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Advisory or Fiduciary Relationship</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;17.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Provisions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;18.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts and Electronic Signatures</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$350,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Healthpeak OP, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(a Maryland limited liability company)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">guaranteed by</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Healthpeak Properties,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(a Maryland corporation)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5.250% Senior Notes Due 2032</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>UNDERWRITING AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">May&nbsp;1, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Wells Fargo Securities, LLC<BR>
550 South Tryon Street, 5th Floor<BR>
Charlotte, North Carolina 28202</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">TD Securities (USA) LLC<BR>
One Vanderbilt Avenue, 11th Floor<BR>
New York, New York 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Mizuho Securities USA LLC<BR>
1271 Avenue of the Americas<BR>
New York, New York 10020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Barclays Capital Inc.<BR>
745 Seventh Avenue<BR>
New York, New York 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">RBC Capital Markets<BR>
Brookfield Place<BR>
200 Vesey Street, 8th Floor<BR>
New York, New York 10281</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As Representatives of the several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Healthpeak OP, LLC, a Maryland limited liability
company (the &ldquo;<B>Operating Company</B>&rdquo;) and a subsidiary of Healthpeak Properties,&nbsp;Inc., a Maryland corporation (the
 &ldquo;<B>Company</B>&rdquo;), confirm their agreement with each of the Underwriters named in Schedule&nbsp;A hereto (collectively, the
 &ldquo;<B>Underwriters</B>,&rdquo; which term shall also include any underwriter substituted as hereinafter provided in Section&nbsp;10
hereof), for whom Wells Fargo Securities, LLC, TD Securities (USA) LLC, Mizuho Securities USA LLC, Barclays Capital Inc. and RBC Capital
Markets, LLC are acting as representatives (the &ldquo;<B>Representatives</B>&rdquo;), with respect to the issue and sale by the Operating
Company and the purchase by the Underwriters, acting severally and not jointly, of the respective amounts set forth in such Schedule
A of $350,000,000 aggregate principal amount of the Operating Company&rsquo;s 5.250% Senior Notes Due 2032 (the &ldquo;<B>Notes</B>&rdquo;),
which will be part of the same series of notes as the $400,000,000 aggregate principal amount of the Operating Company&rsquo;s 5.250%
Senior Notes Due 2032 issued on January&nbsp;17, 2023 (the &ldquo;<B>Previously Issued Notes</B>&rdquo;). The Notes will be fully and
unconditionally guaranteed by the Company (the &ldquo;<B>Guarantee</B>&rdquo; and, together with the Notes, the &ldquo;<B>Securities</B>&rdquo;).
The Previously Issued Notes are outstanding, and the Notes are to be issued, pursuant to an indenture dated November&nbsp;19, 2012 between
the Company and The Bank of New York Mellon Trust Company, N.A. as trustee (the &ldquo;<B>Trustee</B>&rdquo;), as amended and restated
by an amended and restated indenture dated February&nbsp;10, 2023 among the Company, the Operating Company and the Trustee (as so amended
and restated, the &ldquo;<B>Base Indenture</B>&rdquo;), as supplemented by the Thirteenth Supplemental Indenture dated January&nbsp;13,
2023 between the Company and the Trustee (the &ldquo;<B>Thirteenth Supplemental Indenture</B>&rdquo;) and as further supplemented by
the Fourteenth Supplemental Indenture dated February&nbsp;10, 2023 between the Company, the Operating Company and the Trustee (together
with the Thirteenth Supplemental Indenture, the &ldquo;<B>Supplemental Indentures</B>&rdquo; and, together with the Thirteenth Supplemental
Indenture and the Base Indenture, the &ldquo;<B>Indenture</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Company and the Operating
Company have filed with the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) an automatic shelf registration
statement on Form&nbsp;S-3 (Nos.&nbsp;333-269718 and 333-269718-01), which registration statement became effective upon filing under
Rule&nbsp;462(e)&nbsp;of the rules&nbsp;and regulations of the Commission (the &ldquo;<B>1933 Act Regulations</B>&rdquo;) under the Securities
Act of 1933, as amended (the &ldquo;<B>1933 Act</B>&rdquo;). Such registration statement covers the registration of the Securities (among
other securities) under the 1933 Act. Such registration statement, in the form in which it became effective, as amended through the date
hereof, including the information deemed pursuant to Rule&nbsp;430B under the 1933 Act Regulations to be part of the registration statement
at the time of its effectiveness (&ldquo;<B>Rule&nbsp;430B Information</B>&rdquo;) and all documents incorporated or deemed to be incorporated
by reference therein through the date hereof, is hereinafter referred to as the &ldquo;<B>Registration Statement</B>.&rdquo; The Company
and the Operating Company propose to file with the Commission pursuant to Rule&nbsp;424(b)&nbsp;of the 1933&nbsp;Act Regulations the
Prospectus Supplement (as defined in Section&nbsp;3(k)&nbsp;hereof) relating to the Securities and the prospectus, dated February&nbsp;10,
2023 (the &ldquo;<B>Base Prospectus</B>&rdquo;), and have previously advised you of all further information (financial and other) with
respect to the Company and the Operating Company set forth therein. The Base Prospectus together with the Prospectus Supplement, in their
respective forms on the date hereof (being the forms in which they are to be filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;of
the 1933&nbsp;Act Regulations), including all documents incorporated or deemed to be incorporated by reference therein through the date
hereof, are hereinafter referred to as, collectively, the &ldquo;<B>Prospectus</B>,&rdquo; except that if any revised prospectus or prospectus
supplement shall be provided to you by the Company and the Operating Company for use in connection with the offering and sale of the
Securities which differs from the Prospectus (whether or not such revised prospectus or prospectus supplement is required to be filed
by the Company and the Operating Company pursuant to Rule&nbsp;424(b)&nbsp;of the 1933&nbsp;Act Regulations), the term &ldquo;Prospectus&rdquo;
shall refer to such revised prospectus or prospectus supplement, as the case may be, from and after the time it is first provided to
you for such use. The term &ldquo;<B>Pre-Pricing Prospectus</B>,&rdquo; as used in this Agreement, means the preliminary prospectus supplement
dated May&nbsp;1, 2023 and filed with the Commission on May&nbsp;1, 2023 pursuant to Rule&nbsp;424(b)&nbsp;of the 1933 Act Regulations,
together with the Base Prospectus used with such preliminary prospectus supplement in connection with the marketing of the Securities,
in each case as amended or supplemented by the Company and the Operating Company. Unless the context otherwise requires, all references
in this Agreement to documents, financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo;
 &ldquo;stated,&rdquo; &ldquo;described in&rdquo; or &ldquo;referred to&rdquo; in the Registration Statement, the Pre-Pricing Prospectus
or the Prospectus (and all other references of like import) shall be deemed to mean and include all such documents, financial statements
and schedules and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Pre-Pricing
Prospectus or the Prospectus as the case may be; and all references in this Agreement to amendments or supplements to the Registration
Statement, the Pre-Pricing Prospectus or the Prospectus shall be deemed to mean and include the filing of any document under the Securities
Exchange Act of 1934, as amended (the &ldquo;<B>1934&nbsp;Act</B>&rdquo;), after the date of this Agreement which is or is deemed to
be incorporated by reference in the Registration Statement, the Pre-Pricing Prospectus or the Prospectus, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Company and the Operating
Company understand that the Underwriters propose to make a public offering of the Securities as soon as the Representatives deem advisable
after this Agreement has been executed and delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">At or prior to the time
when sales of the Securities were first made (such time, the &ldquo;<B>Time of Sale</B>&rdquo;), the Company and the Operating Company
had prepared the following information (collectively the &ldquo;<B>Time of Sale Information</B>&rdquo;): the Pre-Pricing Prospectus and
each &ldquo;free-writing prospectus&rdquo; (as defined pursuant to Rule&nbsp;405 of the 1933 Act Regulations) listed on Exhibit&nbsp;B
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">As set forth in this
Agreement, references herein to &ldquo;subsidiaries&rdquo; of the Company or similar references shall include, without limitation, the
Operating Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;1. Representations
and Warranties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Operating Company, jointly and severally, represent and warrant to each Underwriter as of the date hereof (such date
being hereinafter referred to as the &ldquo;Representation Date&rdquo;), as of the Time of Sale and as of Closing Time referred to in
Section&nbsp;2 as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(i)&nbsp;<U>Pre-Pricing
Prospectus</U>. No order preventing or suspending the use of the Pre-Pricing Prospectus has been issued by the Commission, and each Pre-Pricing
Prospectus, at the time of filing thereof, complied in all material respects with the 1933 Act and did not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the representations
and warranties in this subsection&nbsp;(i)&nbsp;shall not apply to statements in or omissions from the Pre-Pricing Prospectus made in
reliance upon and in conformity with information furnished to the Company and the Operating Company in writing by any Underwriter through
the Representatives expressly for use in any Pre-Pricing Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(ii)&nbsp;<U>Time
of Sale Information</U>. The Time of Sale Information, at the Time of Sale did not, and at Closing Time will not, contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the representations and warranties in
this subsection&nbsp;(ii)&nbsp;shall not apply to statements in or omissions from the Time of Sale Information made in reliance upon
and in conformity with information furnished to the Company and the Operating Company in writing by any Underwriter through the Representatives
expressly for use in such Time of Sale Information. No statement of material fact included (or to be included) in the Prospectus will
be omitted from the Time of Sale Information and no statement of material fact included in the Time of Sale Information that is required
to be included in the Prospectus will be omitted therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(iii)&nbsp;<U>Issuer
Free Writing Prospectus</U>. The Company and the Operating Company (including their agents and representatives, other than the Underwriters
in their capacity as such) have not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize,
approve or refer to any &ldquo;written communication&rdquo; (as defined in Rule&nbsp;405 of the 1933 Act Regulations) that constitutes
an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company, the Operating Company or
their respective agents and representatives other than the Underwriters in their capacity as such (other than a communication referred
to in clauses&nbsp;(A), (B)&nbsp;and (C)&nbsp;below) an &ldquo;Issuer Free Writing Prospectus&rdquo;) other than (A)&nbsp;any document
not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a)&nbsp;of the 1933 Act or Rule&nbsp;134 of the 1933 Act Regulations,
(B)&nbsp;the Pre-Pricing Prospectus, (C)&nbsp;the Prospectus, (D)&nbsp;the documents listed on Exhibit&nbsp;B hereto as constituting
part of the Time of Sale Information and (E)&nbsp;any electronic road show or other written communications, in each case approved in
writing in advance by the Representatives. Each such Issuer Free Writing Prospectus complied in all material respects with the 1933 Act,
has been or will be (within the time period specified in Rule&nbsp;433 of the 1933 Act Regulations) filed (to the extent required thereby)
in accordance with the 1933 Act and when taken together with the Pre-Pricing Prospectus accompanying, or delivered prior to delivery
of, such Issuer Free Writing Prospectus, did not, and at Closing Time will not, contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; <U>provided</U>, <U>however</U>, that the representations and warranties in this subsection&nbsp;(iii)&nbsp;shall not
apply to statements in or omissions from any Issuer Free Writing Prospectus made in reliance upon and in conformity with information
furnished to the Company and the Operating Company in writing by any Underwriter through the Representatives expressly for use in any
Issuer Free Writing Prospectus. Each Issuer Free Writing Prospectus, as of its issue date and at all subsequent times through the completion
of the public offer and sale of the Securities or until any earlier date that the Company or the Operating Company notified or notifies
the Representatives as described in Section&nbsp;3(f), did not, does not and will not include any information that conflicted, conflicts
or will conflict with the information contained in the Registration Statement, the Prospectus or any Pre-Pricing Prospectus that has
not been superseded or modified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(iv)&nbsp;<U>Compliance
with Registration Requirements</U>. The Registration Statement is an &ldquo;automatic shelf registration statement&rdquo; as defined
under Rule&nbsp;405 of the 1933 Act Regulations that has been filed with the Commission not earlier than three years prior to the date
hereof; and no notice of objection of the Commission to the use of such Registration Statement or any post-effective amendment thereto
pursuant to Rule&nbsp;401(g)(2)&nbsp;of the 1933 Act Regulations has been received by the Company or the Operating Company. Each of the
Registration Statement and the Base Prospectus, at the respective times the Registration Statement and any post-effective amendments
thereto became effective and as of the Representation Date, complied and comply in all material respects with the requirements of the
1933 Act and the 1933 Act Regulations (including Rule&nbsp;415(a)&nbsp;of the 1933 Act Regulations), and the Trust Indenture Act of 1939,
as amended (the &ldquo;<B>1939 Act</B>&rdquo;), and the rules&nbsp;and regulations of the Commission under the 1939 Act (the &ldquo;<B>1939
Act Regulations</B>&rdquo;), and did not and as of the Representation Date and at Closing Time do not contain an untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.
No order suspending the effectiveness of the Registration Statement has been issued under the 1933 Act and no proceedings for that purpose
or pursuant to Section&nbsp;8A of the 1933 Act against the Company or the Operating Company or related to the offering of the Securities
have been instituted or are pending or, to the knowledge of the Company or the Operating Company, are contemplated by the Commission,
and any request on the part of the Commission for additional information has been complied with. The Prospectus, at the Representation
Date (unless the term &ldquo;<B>Prospectus</B>&rdquo; refers to a prospectus which has been provided to the Underwriters by the Company
or the Operating Company for use in connection with the offering of the Securities which differs from the Prospectus filed with the Commission
pursuant to Rule&nbsp;424(b)&nbsp;of the 1933 Act Regulations, in which case at the time it is first provided to the Underwriters for
such use) and at Closing Time, does not and will not include an untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>,
<U>however</U>, that the representations and warranties in this subsection&nbsp;(iv)&nbsp;shall not apply to statements in or omissions
from the Registration Statement or Prospectus made in reliance upon and in conformity with information furnished to the Company and the
Operating Company in writing by any Underwriter through the Representatives expressly for use in the Registration Statement or the Prospectus
or the information contained in any Statement of Eligibility and Qualification of a trustee under the 1939 Act filed as an exhibit to
the Registration Statement (a &ldquo;<B>Form&nbsp;T-1</B>&rdquo;). For purposes of this Section&nbsp;1(a), all references to the Registration
Statement, any post-effective amendments thereto and the Prospectus shall be deemed to include, without limitation, any electronically
transmitted copies thereof filed with the Commission pursuant to its Electronic Data Gathering, Analysis, and Retrieval system or its
Interactive Data Electronic Applications system (collectively, &ldquo;<B>EDGAR</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(v)&nbsp;<U>Incorporated
Documents</U>. The documents filed by the Company and incorporated or deemed to be incorporated by reference into the Registration Statement,
the Prospectus and the Time of Sale Information pursuant to Item&nbsp;12 of Form&nbsp;S-3 under the 1933&nbsp;Act, at the time they were
or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the 1934&nbsp;Act
and the rules&nbsp;and regulations of the Commission thereunder (the &ldquo;<B>1934&nbsp;Act Regulations</B>&rdquo;), and, when read
together and with the other information in the Registration Statement, the Prospectus and the Time of Sale Information, at the respective
times the Registration Statement and any amendments thereto became effective, at the Representation Date, the Time of Sale and at the
Closing Time, did not, do not and will not contain an untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(vi)&nbsp;<U>Independent
Accountants</U>. The accountants who audited the financial statements and supporting schedules included or incorporated by reference
in the Registration Statement and the Prospectus are a registered public accounting firm independent of the Company, as required by the
1933&nbsp;Act and the 1933&nbsp;Act Regulations and the rules&nbsp;and regulations of the Public Company Accounting Oversight Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(vii)&nbsp;<U>Financial
Statements</U>. (A)&nbsp;The financial statements and any supporting schedules of the Company and its consolidated subsidiaries included
or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus present fairly the consolidated
financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their respective operations
for the periods specified; and, (B)&nbsp;except as otherwise stated in the Registration Statement, the Time of Sale Information and the
Prospectus, said financial statements have been prepared in conformity with generally accepted accounting principles applied on a consistent
basis; and (C)&nbsp;the supporting schedules of the Company and its consolidated subsidiaries included or incorporated by reference in
the Registration Statement present fairly the information required to be stated therein; and (D)&nbsp;the selected financial data and
the summary financial information of the Company, if any, included or incorporated by reference in the Registration Statement, the Time
of Sale Information and the Prospectus present fairly the information shown therein as of the dates indicated and have been compiled
on a basis consistent with that of the audited financial statements included or incorporated by reference in the Registration Statement,
the Time of Sale Information and the Prospectus; and (E)&nbsp;any pro forma financial statements and the related notes thereto included
or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus present fairly the information
shown therein, have been prepared in accordance with the Commission&rsquo;s rules&nbsp;and guidelines with respect to pro forma financial
statements and have been properly compiled on the basis described therein, and the assumptions used in the preparation thereof are reasonable
and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein. The interactive
data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the Time of Sale Information
and the Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&rsquo;s
rules&nbsp;and guidelines applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(viii)&nbsp;<U>No
Material Adverse Change in Business</U>. Since the respective dates as of which information is given in the Registration Statement, the
Time of Sale Information and the Prospectus (in each case as supplemented or amended), except as otherwise stated therein or contemplated
thereby, (A)&nbsp;there has been no material adverse change in the condition, financial or otherwise, or in the earnings, business affairs
or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course
of business (&ldquo;<B>Material Adverse Effect</B>&rdquo;), (B)&nbsp;there have been no transactions entered into by the Company or any
of its subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries
considered as one enterprise, and (C)&nbsp;except for regular quarterly dividends on the Company&rsquo;s common stock, par value $1.00
per share (&ldquo;<B>Common Stock</B>&rdquo;) there has been no dividend or distribution of any kind declared, paid or made by the Company
on any class of its capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(ix)&nbsp;<U>Good
Standing of the Company</U>. The Company has been duly incorporated and is validly existing as a corporation in good standing under the
laws of the State of Maryland with corporate power and authority to own, lease and operate its properties and to conduct its business
as described in the Time of Sale Information and the Prospectus; the Company is duly qualified as a foreign corporation to transact business
and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of
property or the conduct of business, except where the failure to so qualify and be in good standing would not have a Material Adverse
Effect; and the Company is in substantial compliance with all laws, ordinances and regulations of each state in which it owns properties
that are material to the properties and business of the Company and its subsidiaries considered as one enterprise in such state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(x)&nbsp;<U>Good
Standing of the Operating Company</U>. The Operating Company has been duly formed and is validly existing as a limited liability company
in good standing under the laws of the State of Maryland with power and authority (limited liability company and other) to own, lease
and operate its properties and to conduct its business as described in the Time of Sale Information and the Prospectus; the Operating
Company is duly qualified as a foreign limited liability company to transact business and is in good standing in each jurisdiction in
which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where
the failure to so qualify and be in good standing would not have a Material Adverse Effect; and the Operating Company is in substantial
compliance with all laws, ordinances and regulations of each state in which it owns properties that are material to the properties and
business of the Operating Company and its subsidiaries considered as one enterprise in such state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xi)&nbsp;<U>Good
Standing of Subsidiaries</U>. Each subsidiary of the Company (other than the Operating Company) which is a significant subsidiary (each,
a &ldquo;<B>Significant Subsidiary</B>&rdquo;) as defined in Rule&nbsp;405 of Regulation&nbsp;C of the 1933 Act Regulations has been
duly organized and is validly existing as a corporation, limited liability company or partnership, as the case may be, in good standing
under the laws of the jurisdiction of its organization, has power and authority as a corporation, limited liability company or partnership,
as the case may be, to own, lease and operate its properties and to conduct its business as described in the Time of Sale Information
and the Prospectus and is duly qualified as a foreign corporation, limited liability company or partnership, as the case may be, to transact
business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or
leasing of property or the conduct of business, except where the failure to so qualify and be in good standing would not have a Material
Adverse Effect; all of the issued and outstanding capital stock of each such corporate subsidiary has been duly authorized and validly
issued, is fully paid and non-assessable and, except for directors&rsquo; qualifying shares, is owned by the Company, directly or through
subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, restriction on voting or transfer or equity;
and all of the issued and outstanding partnership or limited liability company interests of each such subsidiary which is a partnership
or limited liability company, as applicable, have been duly authorized (if applicable) and validly issued and are fully paid and non-assessable
and (except for other partnership or limited liability company interests described in the Time of Sale Information and the Prospectus)
are owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance,
claim or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xii)&nbsp;<U>LLC
Agreement of the Operating Company</U>. The operating agreement of the Operating Company (the &ldquo;<B>LLC Agreement</B>&rdquo;) is
in full force and effect and all of the outstanding membership interests (&ldquo;<B>LLC Interests</B>&rdquo;) in the Operating Company
are duly and validly authorized and issued in accordance with the LLC Agreement. Except as otherwise set forth in the Time of Sale Information
or the Prospectus, all outstanding LLC Interests in the Operating Company are owned by the Company directly or indirectly, free and clear
of any security interest, mortgage, pledge, lien, encumbrance, restriction on voting or transfer or equity. There are no outstanding
options, warrants, or other rights to purchase, agreements or other obligations to issue, or rights to convert any obligations into or
exchange for, any LLC Interests or other securities of or in the Operating Company, except as otherwise set forth in the Time of Sale
Information or the Prospectus or as may be issued pursuant to employee benefit plans disclosed in the Registration Statement, the General
Disclosure Package and the Prospectus or pursuant to the exercise of convertible or exchangeable securities or options disclosed in the
Registration Statement, the General Disclosure Package and the Prospectus. None of the LLC Interests in the Operating Company have been
or will be issued in violation of the preemptive or other similar rights of any securityholder of the Operating Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xiii)&nbsp;<U>REIT
Status</U>. Commencing with its taxable year ending December&nbsp;31, 1985, the Company has at all times operated in such manner as to
qualify as a &ldquo;real estate investment trust&rdquo; under the Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;),
and any predecessor statute thereto, and intends to continue to operate in such manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xiv)&nbsp;<U>Capitalization</U>.
The shares of issued Common Stock have been duly authorized and validly issued and are fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xv)&nbsp;<U>Absence
of Defaults and Conflicts</U>. Neither the Company nor any of its subsidiaries is (i)&nbsp;in violation of its charter or bylaws, limited
liability agreement or other organizational documents, as the case may be, or (ii)&nbsp;in material default in the performance or observance
of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, loan agreement, note (including the
Previously Issued Notes), lease or other instrument to which the Company or any of its subsidiaries is a party or by which it or any
of them or their properties may be bound or to which any of the property or assets of the Company or any of its subsidiaries is subject
and in which the violation or default might result in a Material Adverse Effect; and in the case of the Company and the Operating Company,
the execution, delivery and performance of this Agreement, the Indenture and the Securities and the consummation of the transactions
contemplated herein and therein and compliance by the Company and the Operating Company, as applicable, with their respective obligations
hereunder and thereunder have been duly authorized by all necessary corporate action and will not conflict with or constitute a breach
of, or default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company,
the Operating Company or any of their respective subsidiaries pursuant to, any contract, indenture, mortgage, loan agreement, note, lease
or other instrument to which the Company, the Operating Company or any of their respective subsidiaries is a party or by which it or
any of them may be bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, nor will such
action result in any violation of the provisions of the charter or bylaws of the Company or any law, administrative regulation or administrative
or court order or decree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xvi)&nbsp;<U>Absence
of Proceedings</U>. Except as disclosed in the Registration Statement, the Time of Sale Information or the Prospectus, there is no action,
suit or proceeding before or by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the
Company or the Operating Company, threatened against or affecting, the Company, the Operating Company or any of their respective subsidiaries,
which is required to be disclosed in the Registration Statement, the Time of Sale Information or the Prospectus, or which might result
in any Material Adverse Effect, or which might materially and adversely affect the properties or assets thereof or which might materially
and adversely affect the consummation of this Agreement or any transaction contemplated hereby; all pending legal or governmental proceedings
to which the Company or any of its subsidiaries is a party or of which any of their respective property or assets is the subject which
are not described in or incorporated by reference in the Registration Statement, the Time of Sale Information or the Prospectus, including
ordinary routine litigation incidental to the business, are, considered in the aggregate, not material to the Company or the Operating
Company; and there are no contracts or documents of the Company or any of its subsidiaries which are required to be filed or incorporated
by reference as exhibits to, or incorporated by reference in, the Registration Statement by the 1933&nbsp;Act or by the 1933&nbsp;Act
Regulations which have not been so filed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xvii)&nbsp;<U>Absence
of Further Requirements</U>. No authorization, approval, consent, order or decree of any court or governmental authority or agency is
required for the consummation by the Company and the Operating Company of the transactions contemplated by this Agreement or in connection
with the offering, issuance or sale of the Notes or the Guarantee, as applicable, hereunder, except such as may be required under state
securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xviii)&nbsp;<U>Authorization
of Underwriting Agreement</U>. This Agreement has been duly authorized, executed and delivered by the Company and the Operating Company
and, upon execution and delivery by you, will be a valid and legally binding agreement of the Company and the Operating Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xix)&nbsp;<U>Authorization
of Indenture</U>. The Base Indenture has been duly authorized, executed and delivered by the Company and the Operating Company. The Supplemental
Indentures have been duly authorized and have been duly executed and delivered by the Company and the Operating Company, as applicable,
and by the Trustee, and the Indenture constitutes a valid and legally binding obligation of the Company and the Operating Company, enforceable
against each of the Company and the Operating Company in accordance with its terms, except as the enforcement thereof may be limited
by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting creditor&rsquo;s rights generally
or by general equitable principles. The Indenture has been duly qualified under the 1939 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xx)&nbsp;<U>Authorization
of the Notes and the Guarantee</U>. The Notes have been duly authorized and, when executed, authenticated, issued and delivered pursuant
to this Agreement and the Indenture, will constitute valid and binding obligations of the Operating Company, enforceable against the
Operating Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws relating to or affecting creditors&rsquo; rights generally or by general equitable principles, and will
be in the form contemplated by, and entitled to the benefits of, the Indenture. The Guarantee has been duly authorized and, when the
Notes are executed, authenticated, issued and delivered pursuant to this Agreement and the Indenture, will constitute a valid and binding
obligation of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited
by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors&rsquo; rights generally
or by general equitable principles, and will be in the form contemplated by, and entitled to the benefits of, the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxi)&nbsp;<U>Description
of the Securities</U>. The Securities and the Indenture will conform in all material respects to the respective statements relating thereto
contained in the Prospectus and will be in substantially the respective forms filed or incorporated by reference, as the case may be,
as exhibits to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxii)&nbsp;<U>Seniority
of the Notes</U>. The Notes rank and will rank on a parity with all unsecured indebtedness (other than subordinated indebtedness) of
the Operating Company that is outstanding on the date hereof or that may be incurred hereafter, and senior to any subordinated indebtedness
of the Operating Company that is outstanding on the date hereof or that may be incurred hereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxiii)&nbsp;<U>Title
to Property</U>. The Company and its subsidiaries have good title to all real property or interests in real property owned by it or any
of them in each case free and clear of all liens, encumbrances and defects except such as are stated in or included in documents incorporated
or deemed to be incorporated by reference in the Time of Sale Information or the Prospectus or such as would not have a Material Adverse
Effect; and at the time the Company and its subsidiaries first acquired title or such interest in such real property, the Company and
its subsidiaries obtained satisfactory confirmations (consisting of policies of title insurance or commitments or binders therefor, opinions
of counsel based upon the examination of abstracts, or other evidence deemed appropriate by the Company under the circumstances) confirming
the foregoing. To the best knowledge of the Company and the Operating Company, the instruments securing the Company&rsquo;s real estate
mortgage loans in favor of the Company and its subsidiaries create valid liens upon the real properties described in such instruments
enjoying the priorities intended, subject only to exceptions to title which have no material adverse effect on the value of such interests
in relation to the Company and its subsidiaries considered as one enterprise; and at the time the Company and its subsidiaries first
acquired an interest in such real estate mortgage loans, the Company and its subsidiaries obtained satisfactory confirmations (consisting
of policies of title insurance or commitments or binders therefor, opinions of counsel based upon the examination of abstracts, or other
evidence deemed appropriate by the Company under the circumstances).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxiv)&nbsp;<U>Investment
Company Act</U>. Neither the Company nor the Operating Company is required to be registered, nor, after giving effect to the offering
contemplated hereby and the application of the proceeds thereof as described in the Pre-Pricing Prospectus and the Prospectus, will be
required to be registered under the Investment Company Act of 1940, as amended (the &ldquo;<B>1940 Act</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxv)&nbsp;<U>Rating
of the Notes</U>. The Notes have the respective ratings set forth in the Issuer Free Writing Prospectus identified in Exhibit&nbsp;B
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxvi)&nbsp;<U>Pending
Proceedings and Examinations</U>. The Registration Statement is not the subject of a pending proceeding or examination under Section&nbsp;8(d)&nbsp;or
8(e)&nbsp;of the 1933 Act, and the Company is not the subject of a pending proceeding under Section&nbsp;8A of the 1933 Act in connection
with the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxvii)&nbsp;<U>Disclosure
Controls and Procedures</U>. The Company has established and maintains &ldquo;disclosure controls and procedures&rdquo; (as such term
is defined in Rule&nbsp;13a-15(e)&nbsp;and 15d-15(e)&nbsp;under the 1934 Act) that (i)&nbsp;are designed to ensure that material information
relating to the Company, including its consolidated subsidiaries, is made known to the Company&rsquo;s Chief Executive Officer and its
Chief Financial Officer by others within those entities, particularly during the periods in which the filings made by the Company with
the Commission which it may make under Section&nbsp;13(a), 13(c)&nbsp;or 15(d)&nbsp;of the 1934 Act are being prepared, (ii)&nbsp;have
been evaluated for effectiveness as of the end of the Company&rsquo;s most recent fiscal year and (iii)&nbsp;are effective at a reasonable
assurance level to perform the functions for which they were established.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxviii)&nbsp;<U>Internal
Control</U>. The Company has established and maintains &ldquo;internal control over financial reporting&rdquo; (as such term is defined
in Rule&nbsp;13a-15(f)&nbsp;and 15d-15(f)&nbsp;under the 1934 Act) that (i)&nbsp;are designed to provide reasonable assurance that (A)&nbsp;the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles and (B)&nbsp;the interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus fairly presents the information called for in all material respects and is
prepared in accordance with the Commission&rsquo;s rules&nbsp;and guidelines applicable thereto; and (ii)&nbsp;have been evaluated by
the management of the Company (including the Company&rsquo;s Chief Executive Officer and Chief Financial Officer, in each case, serving
as of the end of the Company&rsquo;s most recent fiscal year) for effectiveness as of the end of the Company&rsquo;s most recent fiscal
year. In addition, not later than the date of the filing with the Commission of the Company&rsquo;s most recent Annual Report on Form&nbsp;10-K,
each of the accountants and the audit committee of the board of directors of the Company had been advised of (x)&nbsp;all significant
deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely
to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information and (y)&nbsp;any fraud,
whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal control
over financial reporting. Since the date of the most recent evaluation of such controls and procedures, there have been no changes in
the Company&rsquo;s internal control over financial reporting or in other factors that have materially affected or are reasonably likely
to materially affect the Company&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxix)&nbsp;<U>Status
Under the 1933 Act</U>. The Company is not an &ldquo;ineligible issuer&rdquo; and is a &ldquo;well-known seasoned issuer,&rdquo; in each
case as defined in the 1933 Act, in each case at the times specified in the 1933 Act in connection with the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxx)&nbsp;<U>Foreign
Corrupt Practices Act</U>. None of the Company, any of the Company&rsquo;s subsidiaries or, to the knowledge of the Company or the Operating
Company, any director, officer, agent or employee of the Company or any of its subsidiaries is aware of or has taken any action, directly
or indirectly, that would result in (a)&nbsp;a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and
the rules&nbsp;and regulations thereunder (the &ldquo;<B>FCPA</B>&rdquo;), including, without limitation, making use of the mails or
any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of
the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &ldquo;foreign
official&rdquo; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign
political office, in contravention of the FCPA or (b)&nbsp;an offense under the Bribery Act of 2010 of the United Kingdom (the &ldquo;<B>UK
Bribery Act</B>&rdquo;), or any other applicable anti-bribery or anti-corruption laws. The Company and the Operating Company and, to
the knowledge of the Company and the Operating Company, the Company&rsquo;s affiliates have conducted their businesses in compliance
in all material respects with the FCPA, the UK Bribery Act and other applicable anti-bribery or anti-corruption laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxxi)&nbsp;<U>Money
Laundering Laws</U>. The operations of the Company and its subsidiaries are in compliance in all material respects with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering
statutes of all applicable jurisdictions, the rules&nbsp;and regulations thereunder and any related or similar rules, regulations or
guidelines, issued, administered or enforced by any governmental agency (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;);
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company or the Operating
Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(xxxii)&nbsp;<U>OFAC</U>.
None of the Company, any of its subsidiaries or, to the knowledge of the Company and the Operating Company, any director, officer, agent,
employee or affiliate of the Company or any of its subsidiaries is currently subject to any United States sanctions administered by the
Office of Foreign Assets Control of the United States Department of the Treasury (&ldquo;<B>OFAC</B>&rdquo;); nor is the Company or any
of its subsidiaries located, organized or resident in a country, region or territory that is the subject or the target of any United
States sanctions administered by OFAC, including, without limitation, Crimea, Zaporizhzhia and Kherson, the so-called Donetsk People&rsquo;s
Republic, the so-called Luhansk People&rsquo;s Republic and any other Covered Region of Ukraine identified pursuant to Executive Order
14065, Cuba,&nbsp;Iran, North Korea or Syria (each, a &ldquo;<B>Sanctioned Country</B>&rdquo;); and none of the Company or any of its
subsidiaries will, directly or indirectly, use the proceeds of the offering of the Notes hereunder, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities
of any person, currently subject to any United States sanctions administered by OFAC, or to fund or facilitate any activities of or business
in any Sanctioned Country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
certificate signed by any officer of the Company or the Operating Company and delivered to the Representatives or to counsel for the
Underwriters shall be deemed a representation and warranty by the Company and the Operating Company, jointly and severally, to you as
to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;2. <U>Sale
and Delivery to Underwriters; Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">On
the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, the Operating
Company agrees to sell to each Underwriter, severally and not jointly, and each Underwriter, severally and not jointly, agrees to purchase
from the Operating Company, the aggregate principal amount of the Notes set forth opposite their names on Schedule A at a purchase price
of 97.706% of the principal amount thereof, plus accrued and unpaid interest from and including January&nbsp;17, 2023 to, but excluding,
the date of delivery of the Notes offered hereby, equal to $5,767,708.33 in the aggregate, plus any additional principal amount of Notes
which such Underwriter may become obligated to purchase pursuant to the provisions of Section&nbsp;10 hereof. The Company agrees to guarantee
the Notes as provided in the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Payment
of the purchase price for, and delivery of certificates for, the Notes shall be made at the office of Latham&nbsp;&amp; Watkins LLP,
10250 Constellation Blvd., Suite&nbsp;1100, Century City, California 90067, or at such other place as shall be agreed upon by you and
the Operating Company, at 7:00&nbsp;A.M., California time, on May&nbsp;10, 2023, or such other time not later than ten business days
after such date as shall be agreed upon by the Representatives, the Company and the Operating Company (such time and date of payment
and delivery being herein called &ldquo;<B>Closing Time</B>&rdquo;). Payment shall be made to the Operating Company by wire transfer
of immediately available funds to a bank account designated by the Operating Company against delivery to the Representatives for the
respective accounts of the Underwriters of certificates for the Notes to be purchased by them. Certificates for the Notes shall be in
such denominations and registered in such names as the Representatives may request in writing at least one business day before Closing
Time. It is understood that each Underwriter has authorized the Representatives, for its account, to accept delivery of, receipt for,
and make payment of the purchase price for, the Notes which such Underwriter has agreed to purchase. Wells Fargo Securities, LLC, individually
and not as representative of the Underwriters, may (but shall not be obligated to) make payment of the purchase price for the Notes to
be purchased by any Underwriter whose check has not been received by Closing Time, but such payment shall not release such Underwriter
from its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;3. <U>Covenants
of the Company and the Operating Company</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Company and the Operating
Company, jointly and severally, covenant with each Underwriter as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compliance
with Securities Regulations and Commission Requests</U>. The Company and the Operating Company will notify the Representatives immediately,
and confirm the notice in writing (i)&nbsp;of the effectiveness of any post-effective amendment to the Registration Statement, (ii)&nbsp;of
the mailing or the delivery to the Commission for filing of the Prospectus or any amendment to the Registration Statement or amendment
or supplement to the Prospectus or any Issuer Free Writing Prospectus or any document to be filed pursuant to the 1934 Act during any
period when the Prospectus is required to be delivered under the 1933 Act, the 1933 Act Regulations, the 1934 Act or the 1934 Act Regulations
in connection with sales of the Securities (or required to be delivered but for Rule&nbsp;172 of the 1933 Act Regulations) (the &ldquo;<B>Prospectus
Delivery Period</B>&rdquo;), (iii)&nbsp;of the receipt of any comments or inquiries from the Commission relating to the Registration
Statement or the Prospectus, (iv)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any amendment
or supplement to the Prospectus or for additional information, (v)&nbsp;of the issuance by the Commission of any order suspending the
effectiveness of the Registration Statement or of any order preventing or suspending the use of the Pre-Pricing Prospectus or the Prospectus,
or the initiation of any proceedings for that purpose or pursuant to Section&nbsp;8A of the 1933 Act, (vi)&nbsp;of the occurrence of
any event at any time as a result of which the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus as then
amended or supplemented would include any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Time
of Sale Information or any such Issuer Free Writing Prospectus is delivered to a purchaser, not misleading, (vii)&nbsp;of the receipt
by the Company or the Operating Company of any notice of objection of the Commission to the use of the Registration Statement or any
post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2)&nbsp;under the 1933 Act, and (viii)&nbsp;of the issuance by any state
securities commission or other regulatory authority of any order suspending the qualification or the exemption from qualification of
the Securities under state securities or Blue Sky laws or the initiation of any proceedings for that purpose. The Company and the Operating
Company will make every reasonable effort to prevent the issuance by the Commission of any such order suspending the effectiveness of
the Registration Statement, preventing or suspending the use of the Pre-Pricing Prospectus or the Prospectus or suspending any such qualification
or exemption of the Securities and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment. The Company
and the Operating Company will provide you with copies of the form of Prospectus and each Issuer Free Writing Prospectus, in such numbers
as you may reasonably request, and file or transmit for filing with the Commission such Prospectus and each Issuer Free Writing Prospectus
(including the pricing term sheet in the form approved by the Representatives and in substantially the form of Exhibit&nbsp;C hereto
(the &ldquo;<B>Term Sheet</B>&rdquo;)) to the extent required by Rule&nbsp;433 of the 1933 Act Regulations in accordance with Rule&nbsp;424(b)&nbsp;of
the 1933&nbsp;Act Regulations by the close of business in New York on the second business day immediately succeeding the date hereof.
The Company and the Operating Company will pay the registration fees for this offering within the time period required by Rule&nbsp;456(b)(1)(i)&nbsp;of
the 1933 Act Regulations (without giving effect to the proviso therein) and in any event prior to Closing Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Filing
of Amendments</U>. During the Prospectus Delivery Period, the Company and the Operating Company will give the Representatives notice
of their intention to file or prepare any amendment to the Registration Statement or any amendment or supplement to the Prospectus (including
any revised prospectus which the Company or the Operating Company proposes for use by the Underwriters in connection with the offering
of the Securities that differs from the prospectus filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;of the 1933&nbsp;Act Regulations,
whether or not such revised prospectus is required to be filed pursuant to Rule&nbsp;424(b)&nbsp;of the 1933&nbsp;Act Regulations), will
furnish the Representatives with copies of any such amendment or supplement a reasonable amount of time prior to such proposed filing
or use, as the case may be, and will not file any such amendment or supplement or use any such prospectus to which the Representatives
or counsel for the Underwriters shall reasonably object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Issuer
Free Writing Prospectuses</U>. Before making, preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing
Prospectus related to the Securities, whether before or after the time that the Registration Statement becomes effective, the Company
and the Operating Company will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing
Prospectus for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus to
which the Representatives reasonably object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Delivery
of Registration Statements</U>. The Company and the Operating Company will deliver to the Representatives as many signed copies of the
Registration Statement as originally filed and of each amendment thereto (including exhibits filed therewith and documents incorporated
or deemed to be incorporated by reference therein) as the Representatives may reasonably request and will also deliver to the Representatives
as many conformed copies of the Registration Statement as originally filed and of each amendment thereto (including documents incorporated
or deemed to be incorporated by reference therein but without exhibits filed therewith) as the Representatives may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Delivery
of Prospectuses</U>. The Company and the Operating Company will furnish to each Underwriter, from time to time during the Prospectus
Delivery Period, such number of copies of the Prospectus (as amended or supplemented) as such Underwriter may reasonably request for
the purposes contemplated by the 1933 Act or the 1934 Act or the respective applicable rules&nbsp;and regulations of the Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Continued
Compliance with Securities Laws</U>. If, at any time during the Prospectus Delivery Period, any event shall occur as a result of which
it is necessary, in the opinion of counsel for the Underwriters or counsel for the Company and the Operating Company, to amend or supplement
the Prospectus in order to make the Prospectus not misleading in the light of the circumstances existing at the time it is delivered
to a purchaser, the Company and the Operating Company will forthwith amend or supplement the Prospectus (in form and substance satisfactory
to counsel for the Underwriters) so that, as so amended or supplemented, the Prospectus will not contain an untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at
the time it is delivered to a purchaser, not misleading, and the Company and the Operating Company will furnish to you a reasonable number
of copies of such amendment or supplement. If, in accordance with the preceding sentence, it shall be necessary to amend or supplement
the Prospectus at any time subsequent to the expiration of nine months after the first date of the public offering of the Securities,
the Underwriters shall bear the expense of preparing, filing and furnishing any such amendment or supplement. If at any time following
issuance of an Issuer Free Writing Prospectus through Closing Time there occurred or occurs an event or development as a result of which
such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement, the Prospectus,
any Pre-Pricing Prospectus or the Time of Sale Information or included or would include an untrue statement of a material fact or omitted
or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing
at that subsequent time, not misleading, the Company and the Operating Company will promptly notify you and will promptly amend or supplement,
at their own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Time
of Sale Information</U>. If at any time prior to Closing Time (A)&nbsp;any event shall occur or condition shall exist as a result of
which the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements therein, in the light of the circumstances, not misleading or (B)&nbsp;it
is necessary to amend or supplement the Time of Sale Information to comply with law, the Company and the Operating Company will immediately
notify the Representatives thereof and forthwith prepare and, subject to paragraph&nbsp;(c)&nbsp;above, file with the Commission (to
the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements
to the Time of Sale Information as may be necessary so that the statements in the Time of Sale Information as so amended or supplemented
will not, in the light of the circumstances, be misleading or so that the Time of Sale Information will comply with law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Blue
Sky Qualifications</U>. The Company and the Operating Company will endeavor, in cooperation with the Underwriters, to qualify the Securities
for offering and sale under the applicable securities laws of such states and other jurisdictions of the United States as you may designate;
<U>provided</U>, <U>however</U>, that the Company and the Operating Company shall not be obligated to file any general consent to service
of process or to qualify as a foreign corporation in any jurisdiction in which it is not so qualified. In each jurisdiction in which
the Securities shall have been so qualified, the Company and the Operating Company will file such statements and reports as may be required
by laws of such jurisdiction to continue such qualification in effect for as long as may be required for the distribution of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Earnings
Statement</U>. The Company will make generally available to its security holders as soon as practicable, but not later than 90 days after
the close of the period covered thereby, an earnings statement (in form complying with the provisions of Rule&nbsp;158 of the 1933 Act
Regulations) covering the twelve month period beginning not later than the first day of the Company&rsquo;s fiscal quarter next following
the &ldquo;effective date&rdquo; (as defined in said Rule&nbsp;158) of the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Use
of Proceeds</U>. The Operating Company will use the net proceeds received by it from the sale of the Securities in the manner to be specified
in the Prospectus Supplement under &ldquo;Use of Proceeds.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Preparation
of Prospectus Supplement</U>. Immediately following the execution of this Agreement, the Company and the Operating Company will prepare
a prospectus supplement, dated the date hereof (the &ldquo;<B>Prospectus Supplement</B>&rdquo;), containing the terms of the Securities,
the plan of distribution thereof and such other information as may be required by the 1933 Act or the 1933 Act Regulations or as the
Representatives, the Company and the Operating Company deem appropriate, and will file or transmit for filing with the Commission in
accordance with Rule&nbsp;424(b)&nbsp;of the 1933 Act Regulations copies of the Prospectus (including such Prospectus Supplement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Reporting
Requirements</U>. Each of the Company and the Operating Company, during the Prospectus Delivery Period, will file promptly all documents
required to be filed with the Commission pursuant to Section&nbsp;13, 14 or 15 of the 1934 Act within the time periods required by the
1934 Act and the 1934 Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Lock-up
Period</U>. Each of the Company and the Operating Company, during the period beginning on the date hereof and continuing to and including
Closing Time (the &ldquo;<B>Lock-Up Period</B>&rdquo;), will not offer, sell, contract to sell or otherwise dispose of any debt securities
issued or guaranteed by the Company or the Operating Company or warrants to purchase debt securities of the Company or the Operating
Company substantially similar to the Securities (other than (i)&nbsp;the Securities or (ii)&nbsp;commercial paper issued in the ordinary
course of business), without the prior written consent of the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Record
Retention</U>. Each of the Company and the Operating Company will, pursuant to reasonable procedures developed in good faith, retain
copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule&nbsp;433 of the 1933 Act
Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;4. <U>Payment
of Expenses</U>. The Company and the Operating Company, jointly and severally, will pay all expenses incident to the performance of their
respective obligations under this Agreement, including (i)&nbsp;the printing and filing of the Registration Statement as originally filed
and of each amendment thereto, and the Time of Sale Information, the Pre-Pricing Prospectus and the Prospectus and any amendments or
supplements thereto and any &ldquo;Canadian&rdquo; wrappers, (ii)&nbsp; the fees and expenses of the Trustee, including the fees and
disbursements of counsel for the Trustee in connection with the Indenture and the Securities, (iii)&nbsp;any fees payable in connection
with the rating of the Notes, (iv)&nbsp;the preparation, issuance and delivery of the certificates for the Notes to you, (v)&nbsp;the
fees and disbursements of the Company&rsquo;s and the Operating Company&rsquo;s counsel and accountants, as applicable, (vi)&nbsp;the
qualification of the Securities under securities laws in accordance with the provisions of Section&nbsp;3(h)&nbsp;hereof, including filing
fees and the reasonable fees and disbursements of counsel for the Underwriters in connection therewith and in connection with the preparation
of a Blue Sky Survey, (vii)&nbsp;the printing and delivery to the Underwriters in quantities as hereinabove stated of copies of the Registration
Statement as originally filed and of each amendment thereto, the Pre-Pricing Prospectus, any Issuer Free Writing Prospectus and of the
Prospectus and any amendments or supplements thereto, (viii)&nbsp;the printing and delivery to you of copies of the Blue Sky Survey,
and (ix)&nbsp;any fees or expenses of a depositary in connection with holding the securities in book-entry form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If this Agreement is
cancelled or terminated by the Representatives in accordance with the provisions of Section&nbsp;5 or Section&nbsp;9(a)(i)&nbsp;hereof,
the Company and the Operating Company shall reimburse you for all of your out-of-pocket expenses, including the reasonable fees and disbursements
of counsel for the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;5. <U>Conditions
of the Underwriters&rsquo; Obligations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The obligations of the
Underwriters hereunder are subject to the accuracy of the representations and warranties of the Company and the Operating Company herein
contained, to the performance by the Company and the Operating Company of its obligations hereunder, and to the following further conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effectiveness
of Registration Statement</U>. At Closing Time no order suspending the effectiveness of the Registration Statement shall have been issued
under the 1933&nbsp;Act or proceedings therefor initiated or threatened by the Commission pursuant to Rule&nbsp;401(g)(2)&nbsp;of the
1933 Act Regulations or pursuant to Section&nbsp;8A of the 1933 Act. The Prospectus and each Issuer Free Writing Prospectus shall have
been filed or transmitted for filing with the Commission pursuant to Rule&nbsp;424(b)&nbsp;of the 1933 Act Regulations (in the case of
an Issuer Free Writing Prospectus, to the extent required by Rule&nbsp;433 of the 1933 Act Regulations) and prior to the Closing Time
the Company and the Operating Company shall have provided evidence satisfactory to the Representatives of such timely filing or transmittal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Opinions</U>.
At Closing Time the Representatives shall have received:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
favorable opinions and negative assurance letter, dated as of Closing Time, of Latham&nbsp;&amp; Watkins LLP, special corporate and tax
counsel to the Company and the Operating Company, as set forth in Exhibit&nbsp;A hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
favorable opinion, dated as of Closing Time, of Ballard Spahr&nbsp;LLP, Maryland corporate counsel for the Company and the Operating
Company, in form and scope satisfactory to counsel for the Underwriters, to the effect that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Maryland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Operating Company has been duly formed and is validly existing as a limited liability company in good standing under the laws of the
State of Maryland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has the corporate power and authority, and the Operating Company has the limited liability company power and authority, to own,
lease and operate their respective properties and to conduct their respective business as described in the Time of Sale Information and
the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
authorized capital stock of the Company is as set forth in the Base Prospectus under the caption &ldquo;Description of Capital Stock.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery of the Indenture have been duly and validly authorized by all necessary corporate action on the part of the Company,
acting in its own capacity and in its capacity as managing member of the Operating Company, as applicable, under its charter and bylaws
and the Maryland General Corporation Law (the &ldquo;MGCL&rdquo;). The Indenture has been duly executed and delivered by the Company,
acting in its own capacity and in its capacity as managing member of the Operating Company, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
issuance of the Notes pursuant to the Indenture, and the offer and sale of the Notes pursuant to this Agreement, have been duly authorized
by all necessary corporate action on the part of the Company, acting in its own capacity and in its capacity as managing member of the
Operating Company, as applicable, under its charter and bylaws and the MGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution, delivery and performance of this Agreement has been duly and validly authorized by all necessary corporate action on the part
of the Company under its charter and bylaws and the MGCL. This Agreement has been duly executed and delivered by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery of the Agreement by the Operating Company has been duly and validly authorized by all necessary limited liability
company action on the part of the Operating Company under its articles of organization and LLC Agreement and the Maryland Limited Liability
Company Act (the &ldquo;Act&rdquo;). The Agreement has been duly executed and delivered by the Operating Company. The performance of
the Agreement by the Operating Company has been duly and validly authorized by all necessary limited liability company action on the
part of the Operating Company under its Articles of Organization and LLC Agreement and the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
issuance and sale of the Notes by the Operating Company and the Guarantee by the Company and the compliance by the Company and the Operating
Company with the provisions of this Agreement and the Indenture and the consummation of the transactions contemplated hereby and thereby,
will not result in any violation of the provisions of the charter or bylaws of the Company, or under the Articles of Organization and
LLC Agreement of the Operating Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
authorization, approval, consent, decree or order of any Maryland court or governmental authority or agency is required under the MGCL
for the consummation by the Company or the Operating Company of the transactions contemplated by this Agreement or in connection with
the sale of the Securities hereunder, except such as may have been obtained or rendered, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">In rendering
its opinion, Ballard Spahr&nbsp;LLP shall state that each of Sidley Austin&nbsp;LLP, in rendering its opinion pursuant to Section&nbsp;5(b)(3),
and Latham&nbsp;&amp; Watkins LLP, in rendering its opinions pursuant to Section&nbsp;5(b)(1), may rely upon such opinion as to matters
arising under the laws of the State of Maryland.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
favorable opinion, dated as of Closing Time, of Sidley Austin&nbsp;LLP, counsel to the Underwriters, with respect to such matters as
the Representatives may reasonably request. In rendering such opinion, Sidley Austin&nbsp;LLP may rely upon the opinion of Ballard Spahr&nbsp;LLP,
rendered pursuant to Section&nbsp;5(b)(2), as to matters arising under the laws of the State of Maryland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
giving its opinion required by subsection&nbsp;(b)(3)&nbsp;of this Section, Sidley Austin&nbsp;LLP shall additionally state that no facts
have come to its attention that have caused it to believe that the Registration Statement, at the time of its effective date and at the
date of the Prospectus Supplement, contained an untrue statement of a material fact or omitted to state a material fact required to be
stated therein or necessary to make the statements therein not misleading, that the Time of Sale Information, at the Time of Sale, contained
an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements
therein not misleading, or that the Prospectus, as of the date of the Prospectus Supplement or at Closing Time, included or includes
an untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; it being understood that such counsel shall express no
belief with respect to (i)&nbsp;the financial statements, schedules and other financial data included or incorporated by reference in
or omitted from the Registration Statement, the Time of Sale Information or the Prospectus or (ii)&nbsp;any Form&nbsp;T-1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">In giving their
opinions, Latham&nbsp;&amp; Watkins&nbsp;LLP, Ballard Spahr&nbsp;LLP and Sidley Austin&nbsp;LLP may rely, to the extent recited therein,
(A)&nbsp;as to all matters of fact, upon certificates and written statements of officers of the Company, acting in its own capacity and
in its capacity as managing member of the Operating Company, and (B)&nbsp;as to the qualification and good standing of the Company, the
Operating Company and each Significant Subsidiary to do business in any state or jurisdiction, upon certificates of appropriate government
officials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Officers&rsquo;
Certificate</U>. At Closing Time there shall not have been, since the date hereof or since the respective dates as of which information
is given in the Registration Statement and the Prospectus or the Time of Sale Information, any material adverse change in the condition,
financial or otherwise, or in the earnings, business affairs or business prospects of the Company, the Operating Company and their respective
subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business, and you shall have received a certificate
of the President or a Vice President of the Company and of the chief financial or chief accounting officer of the Company, on behalf
of the Company in its own capacity and in its capacity as managing member of the Operating Company, dated as of Closing Time, to the
effect that (i)&nbsp;there has been no such material adverse change, (ii)&nbsp;the representations and warranties in Section&nbsp;1 hereof
are true and correct with the same force and effect as though expressly made at and as of Closing Time, (iii)&nbsp;the Company and the
Operating Company have performed or complied with all agreements and satisfied all conditions on their respective parts to be performed
or satisfied at or prior to Closing Time, (iv)&nbsp;no order suspending the effectiveness of the Registration Statement has been issued
and no proceedings for that purpose have been initiated or, to the best knowledge and information of such officer, threatened by the
Commission, (v)&nbsp;no examination pursuant to Section&nbsp;8(c)&nbsp;of the 1933 Act concerning the Registration Statement has been
initiated by the Commission, and (vi)&nbsp;the Company and the Operating Company have not become the subject of a proceeding under Section&nbsp;8A
of the 1933 Act in connection with the offering of the Securities. As used in this Section&nbsp;5(c), the term &ldquo;Prospectus&rdquo;
means the Prospectus in the form first used to confirm sales of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Accountants&rsquo;
Comfort Letter</U>. At the time of the execution of this Agreement, the Representatives shall have received a letter from Deloitte&nbsp;&amp;
Touche&nbsp;LLP, dated such date, in form and substance satisfactory to the Representatives, containing statements and information of
the type ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect to financial statements
and financial information included and incorporated by reference in the Registration Statement, the Time of Sale Information and the
Prospectus (including, without limitation, the pro forma financial statements) and each substantially in the same form as the draft letter
previously delivered to and approved by the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Bring-down
Comfort Letter</U>. At Closing Time, the Representatives shall have received a letter from Deloitte&nbsp;&amp; Touche&nbsp;LLP, dated
as of Closing Time, to the effect that they reaffirm the statements made in their letter furnished pursuant to subsection&nbsp;(d)&nbsp;of
this Section, except that the specified date referred to therein shall be a date not more than three business days prior to Closing Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Additional
Documents</U>. At Closing Time, counsel for the Underwriters shall have been furnished with such documents and opinions as they may reasonably
require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated and related proceedings,
or in order to evidence the accuracy and completeness of any of the representations and warranties, or the fulfillment of any of the
conditions, herein contained; and all proceedings taken by the Company and the Operating Company in connection with the issuance and
sale of the Securities as herein contemplated shall be satisfactory in form and substance to the Representatives and counsel for the
Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Maintenance
of Ratings</U>. The Company and the Operating Company shall have delivered to the Representatives a letter, dated Closing Time, from
each such rating agency, or other evidence satisfactory to the Representatives, confirming that the Notes have the ratings set forth
in the Issuer Free Writing Prospectus identified in Exhibit&nbsp;B hereto; and since the date of this Agreement, there shall not have
occurred a downgrading in the rating assigned to the Notes or any other securities of or guaranteed by the Company or the Operating Company
(including the Previously Issued Notes) by any &ldquo;nationally recognized statistical rating organization,&rdquo; as that term is defined
by the Commission for purposes of Section&nbsp;3(a)(62) of the 1934 Act, and since the date of this Agreement, no such organization shall
have publicly announced that it has placed the Notes or any other securities of or guaranteed by the Company or the Operating Company
on what is commonly termed a &ldquo;watch list&rdquo; for possible down-grading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If any condition specified
in this Section&nbsp;shall not have been fulfilled when and as required to be fulfilled, this Agreement may be terminated by the Representatives
by notifying the Company and the Operating Company at any time at or prior to Closing Time, and such termination shall be without liability
of any party to any other party except as provided in Section&nbsp;4 hereof. Notwithstanding any such termination, the provisions of
Sections&nbsp;1, 4, 6, 7 and 8 shall remain in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;6. <U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Indemnification
of the Underwriters</U>. The Company and the Operating Company, jointly and severally, agree to indemnify and hold harmless each Underwriter,
its directors, officers and agents, and each person, if any, who controls any Underwriter within the meaning of Section&nbsp;15 of the
1933&nbsp;Act or Section&nbsp;20 of the 1934&nbsp;Act, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(i)&nbsp;against
any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement (or any amendment thereto), or any omission or alleged omission
therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading or arising out
of any untrue statement or alleged untrue statement of a material fact contained in the Pre-Pricing Prospectus or the Prospectus (or
any amendment or supplement thereto), or any Issuer Free Writing Prospectus or any Time of Sale Information or any &ldquo;issuer information&rdquo;
(as defined in Rule&nbsp;433(h)&nbsp;under the 1933 Act), filed or required to be filed pursuant to Rule&nbsp;433(a)&nbsp;under the 1933
Act, any information provided to the investors by, or with the approval of, the Company in connection with any offering of the Securities,
including any roadshow or investor presentation made to investors by the Company (whether in person or electronically) or the omission
or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(ii)&nbsp;against
any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement
of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever
based upon any such untrue statement or omission, or any such alleged untrue statement or omission, if such settlement is effected with
the written consent of the Company and the Operating Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">(iii)&nbsp;against
any and all expense whatsoever, as incurred (including, subject to Section&nbsp;6(c)&nbsp;hereof, the fees and disbursements of counsel
chosen by the Representatives), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation
or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement
or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i)&nbsp;or (ii)&nbsp;above;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>provided</U></FONT>,
<U>however</U>, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising
out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written
information furnished to the Company and the Operating Company by any Underwriter through the Representatives expressly for use in the
Registration Statement (or any amendment thereto) or the Prospectus or any Pre-Pricing Prospectus (or any amendment or supplement thereto),
or any Issuer Free Writing Prospectus or any Time of Sale Information, or made in reliance upon the Trustee&rsquo;s Form&nbsp;T-1 filed
as an exhibit to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Indemnification
of the Company, the Operating Company and the Company&rsquo;s Directors and Officers</U>. Each Underwriter severally and not jointly
agrees to indemnify and hold harmless the Company, the Operating Company, the Company&rsquo;s directors, each of the Company&rsquo;s
officers who signed the Registration Statement on behalf of the Company in its own capacity or on behalf of the Company in its capacity
as managing member of the Operating Company, and each person, if any, who controls the Company or the Operating Company within the meaning
of Section&nbsp;15 of the 1933&nbsp;Act or Section&nbsp;20 of the 1934 Act against any and all loss, liability, claim, damage and expense
described in the indemnity contained in subsection&nbsp;(a)&nbsp;of this Section, as incurred, but only with respect to untrue statements
or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendment thereto) or the Prospectus
or any Pre-Pricing Prospectus (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus or any Time of Sale Information
in reliance upon and in conformity with written information furnished to the Company and the Operating Company by any Underwriter through
the Representatives expressly for use therein, it being understood and agreed upon that such information shall solely consist of the
following: (i)&nbsp;the information in the third paragraph under the caption &ldquo;Underwriting (Conflicts of Interest)&rdquo; in the
Pre-Pricing Prospectus and Prospectus concerning discounts; (ii)&nbsp;the second sentence in the sixth paragraph under the caption &ldquo;Underwriting
(Conflicts of Interest)&rdquo; in the Pre-Pricing Prospectus and Prospectus concerning market making; and (iii)&nbsp;the information
in the eighth paragraph under the caption &ldquo;Underwriting (Conflicts of Interest)&rdquo; in the Pre-Pricing Prospectus and Prospectus
solely as it relates to the Underwriters concerning stabilizing transactions, overallotment and syndicate covering transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Actions
Against Parties; Notification</U>. Each indemnified party shall give written notice as promptly as reasonably practicable to each indemnifying
party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying
party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced as a result
thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement.
In the case of parties indemnified pursuant to Section&nbsp;6(a)&nbsp;above, counsel to the indemnified parties shall be selected by
the Representatives, and, in the case of parties indemnified pursuant to Section&nbsp;6(b)&nbsp;above, counsel to the indemnified parties
shall be selected by the Company. An indemnifying party may participate at its own expense in the defense of any such action; <U>provided</U>,
<U>however</U>, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to
the indemnified party. In no event shall the indemnifying parties be liable for fees and expenses of more than one counsel (in addition
to any local counsel) separate from their own counsel for all indemnified parties in connection with any one action or separate but similar
or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall,
without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect
to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever
in respect of which indemnification or contribution could be sought under Section&nbsp;6 or Section&nbsp;7 hereof (whether or not the
indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i)&nbsp;includes an unconditional
release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii)&nbsp;does
not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Settlement
without Consent if Failure to Reimburse</U>. If at any time an indemnified party shall have requested an indemnifying party to reimburse
the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of
the nature contemplated by Section&nbsp;6(a)(ii)&nbsp;effected without its written consent if (i)&nbsp;such settlement is entered into
more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii)&nbsp;such indemnifying party shall have received
notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii)&nbsp;such indemnifying
party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>EDGAR</U>.
For purposes of this Section&nbsp;6, all references to the Registration Statement, any Pre-Pricing Prospectus,&nbsp;Issuer Free Writing
Prospectus or the Prospectus, or any amendment or supplement to any of the foregoing, shall be deemed to include, without limitation,
any electronically transmitted copies thereof filed with the Commission pursuant to EDGAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;7. <U>Contribution</U>.
If the indemnification provided for in Section&nbsp;6 hereof is for any reason unavailable to or insufficient to hold harmless an indemnified
party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute
to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, (i)&nbsp;in
such proportion as is appropriate to reflect the relative benefits received by the Company and the Operating Company, on the one hand,
and the Underwriters, on the other hand, from the offering of the Securities pursuant to this Agreement or (ii)&nbsp;if the allocation
provided by clause&nbsp;(i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause&nbsp;(i)&nbsp;above but also the relative fault of the Company and the Operating Company, on the one hand,
and of the Underwriters, on the other hand, in connection with the statements or omissions which resulted in such losses, liabilities,
claims, damages or expenses, as well as any other relevant equitable considerations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The relative benefits
received by the Company and the Operating Company, on the one hand, and the Underwriters, on the other hand, in connection with the offering
of the Securities pursuant to this Agreement shall be deemed to be in the same respective proportions that the total net proceeds from
the offering of the Securities pursuant to this Agreement (before deducting expenses) received by the Operating Company and the total
underwriting discount received by the Underwriters, in each case as set forth on the cover of the Prospectus Supplement, bear to the
aggregate public offering price of the Notes as set forth on such cover.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The relative fault of
the Company and the Operating Company, on the one hand, and the Underwriters, on the other hand, shall be determined by reference to,
among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a
material fact relates to information supplied by the Company and the Operating Company or by the Underwriters and the parties&rsquo;
relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The Company, the Operating
Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;7 were determined
by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above
in this Section&nbsp;7. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and
referred to above in this Section&nbsp;7 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified
party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency
or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged
omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Notwithstanding the provisions
of this Section&nbsp;7, no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at
which the Notes underwritten by it were offered exceeds the amount of any damages which such Underwriter has otherwise been required
to pay by reason of any such untrue or alleged untrue statement or omission or alleged omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">No person guilty of fraudulent
misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the 1933&nbsp;Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">For purposes of this
Section&nbsp;7, each director, officer and agent of an Underwriter, and each person, if any, who controls an Underwriter within the meaning
of Section&nbsp;15 of the 1933&nbsp;Act or Section&nbsp;20 of the 1934&nbsp;Act shall have the same rights to contribution as such Underwriter,
and each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls
the Company or the Operating Company within the meaning of Section&nbsp;15 of the 1933&nbsp;Act or Section&nbsp;20 of the 1934&nbsp;Act
shall have the same rights to contribution as the Company or the Operating Company, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;8. <U>Representations,
Warranties and Agreements to Survive Delivery</U>. All representations, warranties and agreements of the Company and the Operating Company
contained in this Agreement, or contained in certificates of officers of the Company or the Operating Company submitted pursuant hereto,
shall remain operative and in full force and effect, regardless of any investigation made by or on behalf of any Underwriter or any controlling
person, or by or on behalf of the Company and the Operating Company, and shall survive delivery of the Notes to the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;9. <U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Representatives may terminate this Agreement, by notice to the Company and the Operating Company, at any time at or prior to Closing
Time (i)&nbsp;if there has been since the date of this Agreement or since the respective dates as of which information is given in the
Prospectus or the Time of Sale Information, any material adverse change in the condition, financial or otherwise, or in the earnings,
business affairs or business prospects of the Company, the Operating Company and their respective subsidiaries considered as one enterprise,
whether or not arising in the ordinary course of business, (ii)&nbsp;if there has occurred any material adverse change in the financial
markets in the United States, any outbreak of hostilities or other calamity or crisis or change or development involving a prospective
change in national or international political, financial or economic conditions, in each case the effect of which on the financial markets
of the United States is such as to make it, in the judgment of the Representatives, impracticable to market the Securities or enforce
contracts for the sale of the Securities, (iii)&nbsp;if trading in any securities of the Company or the Operating Company has been suspended
by the Commission or a national securities exchange, or if trading generally on either the New York Stock Exchange or in the Nasdaq Global
Market has been suspended, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices for securities have
been required, by the New York Stock Exchange or by the Nasdaq Global Market or by order of the Commission, the Financial Industry Regulatory
Authority or any other governmental authority, or a material disruption has occurred in commercial banking or securities settlement or
clearance services in the United States, or (iv)&nbsp;if a banking moratorium has been declared by either federal, New York, Maryland
or California authorities. As used in this Section&nbsp;9(a), the term &ldquo;Prospectus&rdquo; means the Prospectus in the form first
used to confirm sales of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
this Agreement is terminated pursuant to this Section, such termination shall be without liability of any party to any other party except
as provided in Section&nbsp;4 hereof. Notwithstanding any such termination, the provisions of Sections&nbsp;4, 6, 7 and 8 shall remain
in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;10. <U>Default
by One or More of the Underwriters</U>. If one or more of the Underwriters shall fail at Closing Time to purchase the Notes which it
or they are obligated to purchase under this Agreement (the &ldquo;<B>Defaulted Securities</B>&rdquo;), the Representatives shall have
the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Underwriters, or any other underwriters,
to purchase all, but not less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein set
forth; if, however, the Representatives shall not have completed such arrangements within such 24 hour period, then:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
the aggregate principal amount of Defaulted Securities does not exceed 10% of the aggregate principal amount of the Notes to be purchased,
each of the non-defaulting Underwriters shall be obligated, severally and not jointly, to purchase the full amount thereof in the proportions
that their respective underwriting obligations hereunder bear to the underwriting obligations of all non-defaulting Underwriters, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
the aggregate principal amount of Defaulted Securities exceeds 10% of the aggregate principal amount of the Notes to be purchased on
such date, this Agreement shall terminate without liability on the part of any non-defaulting Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">No action taken pursuant
to this Section&nbsp;shall relieve any defaulting Underwriter from liability in respect of its default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">In the event of any such
default which does not result in a termination of this Agreement, either the Representatives, on the one hand, or the Company and the
Operating Company, on the other hand, shall have the right to postpone Closing Time for a period not exceeding seven days in order to
effect any required changes in the Registration Statement or Prospectus or in any other documents or arrangements. As used herein, the
term &ldquo;Underwriter&rdquo; includes any person substituted for an Underwriter under this Section&nbsp;10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;11. <U>Certain
Agreements of the Underwriters</U>. Each Underwriter hereby represents and agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">It
has not and will not use, authorize use of, refer to, or participate in the plan for use of, any &ldquo;free writing prospectus,&rdquo;
as defined in Rule&nbsp;405 of the 1933 Act Regulations other than (i)&nbsp;a free writing prospectus that, solely as a result of use
by the Underwriter, would not trigger an obligation to file such free writing prospectus with the Commission pursuant to Rule&nbsp;433
of the 1933 Act Regulations, (ii)&nbsp;any Issuer Free Writing Prospectus listed on Exhibit&nbsp;B or prepared pursuant to Section&nbsp;1(a)(iii)&nbsp;or
Section&nbsp;3(c)&nbsp;above (including any electronic road show), or (iii)&nbsp;any free writing prospectus prepared by such Underwriter
and approved in writing by the Company in advance of the use of such free writing prospectus. Notwithstanding the foregoing, the Underwriters
may use a term sheet substantially in the form of Exhibit&nbsp;C hereto without the consent of the Company and the Operating Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">It
is not subject to any pending proceeding under Section&nbsp;8A of the 1933 Act with respect to the offering (and will promptly notify
the Company and the Operating Company if any such proceeding against it is initiated during the Prospectus Delivery Period).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;12. <U>Notices</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Unless otherwise provided
herein, all notices required under the terms and provisions hereof shall be in writing, either delivered by hand, by mail or by email,
and any such notice shall be effective when received at the address specified below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If to the Company or
the Operating Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Healthpeak Properties,&nbsp;Inc.<BR>
4600 South Syracuse Street, Suite&nbsp;500<BR>
Denver, Colorado 80237<BR>
Attention: Jeffrey H. Miller<BR>
Email: jhmiller@healthpeak.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">With a copy (which shall not constitute notice)
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Lewis W. Kneib,&nbsp;Esq.<BR>
Latham&nbsp;&amp; Watkins&nbsp;LLP<BR>
10250 Constellation Blvd., Suite&nbsp;1100<BR>
Century City, California 90067<BR>
Email: lewis.kneib@lw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">If to the Underwriters,
delivered by fax or by email with a confirmation copy mailed to the addresses set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">Wells Fargo Securities, LLC<BR>
550 South Tryon Street, 5th Floor<BR>
Charlotte, North Carolina 28202<BR>
Attention: Transaction Management<BR>
Email: tmgcapitalmarkets@wellsfargo.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">TD Securities (USA) LLC<BR>
One Vanderbilt Avenue, 11th Floor<BR>
New York, New York 10017<BR>
Attention: Transaction Advisory<BR>
Email: ustransactionadvisory@tdsecurities.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">Mizuho Securities USA LLC<BR>
1271 Avenue of the Americas<BR>
New York, New York 10020<BR>
Attention: Debt Capital Markets<BR>
Fax: 212-205-7812</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">Barclays Capital Inc.<BR>
745 Seventh Avenue<BR>
New York, New York 10019<BR>
Attention: Syndicate Registration<BR>
Fax: (646) 834-8133</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">RBC
Capital Markets, LLC<BR>
Brookfield Place, 200 Vesey Street, 8th Floor<BR>
New York, New York 10281<BR>
Telephone: (212) 618-7706<BR>
Email: </FONT><U>TMGUS@rbccm.com</U><BR>
Attention: DCM Transaction Management/Scott Primrose</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">With a copy (which shall
not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">Sharon R. Flanagan,&nbsp;Esq.<BR>
Sidley Austin&nbsp;LLP<BR>
555 California Street, Suite&nbsp;2000<BR>
San Francisco, California 94104-1715<BR>
Email: sflanagan@sidley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">J. Gerard Cummins,&nbsp;Esq.<BR>
Sidley Austin&nbsp;LLP<BR>
787 Seventh Avenue<BR>
New York, New York 10019<BR>
Email: jcummins@sidley.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">or at such other address as such party may
designate from time to time by notice duly given in accordance with the terms of this Section&nbsp;12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;13. <U>Parties</U>.
This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Company, the Operating Company and their respective
successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation,
other than the Underwriters, the Company, the Operating Company and their respective successors and the controlling persons and the officers
and directors referred to in Sections&nbsp;6 and 7 hereof and their heirs and legal representatives any legal or equitable right, remedy
or claim under or in respect of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof
are intended to be for the sole and exclusive benefit of the Underwriters, the Company, the Operating Company and their respective successors,
and said controlling persons and said officers and directors and their heirs and legal representatives, and for the benefit of no other
person, firm or corporation. No purchaser of Notes from any Underwriter shall be deemed to be a successor merely by reason of such purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;14. <U>Governing
Law and Time</U>. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to
agreements made and to be performed in such State. Unless stated otherwise, all specified times of day refer to New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;15. <U>Recognition
of the U.S. Special Resolution Regimes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation,
were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">For purposes of this
Section&nbsp;15: (A)&nbsp;a &ldquo;BHC Act Affiliate&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall
be interpreted in accordance with, 12 U.S.C. &sect; 1841(k)&#894; (B)&nbsp;&ldquo;<B>Covered Entity</B>&rdquo; means any of the following:
(i)&nbsp;a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b)&#894;
(ii)&nbsp;a &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b)&#894;
or (iii)&nbsp;a &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b)&#894;
(C)&nbsp;&ldquo;Default Right&rdquo; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R.
 &sect;&sect; 252.81, 47.2 or 382.1, as applicable&#894; and (D)&nbsp;&ldquo;U.S. Special Resolution Regime&rdquo; means each of (i)&nbsp;the
Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform
and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;16. <U>No
Advisory or Fiduciary Relationship</U>. The Company and the Operating Company acknowledge and agree, jointly and severally, that (i)&nbsp;the
purchase and sale of the Securities pursuant to this Agreement, including the determination of the public offering price of the Notes
and any related discounts and commissions, are arm&rsquo;s-length commercial transactions between the Company and the Operating Company,
on the one hand, and the Underwriters, on the other hand, (ii)&nbsp;in connection with the offering contemplated hereby and the process
leading to such transaction each Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company,
the Operating Company or their respective stockholders, creditors, employees or any other party, (iii)&nbsp;no Underwriter has assumed
or will assume an advisory or fiduciary responsibility in favor of the Company or the Operating Company with respect to the offering
contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the
Company and the Operating Company on other matters) and no Underwriter has any obligation to the Company and the Operating Company with
respect to the offering contemplated hereby except the obligations expressly set forth in this Agreement, (iv)&nbsp;the Underwriters
and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the
Company and the Operating Company, and (v)&nbsp;no Underwriter has provided any legal, financial, accounting, regulatory or tax advice
with respect to the offering contemplated hereby and the Company and the Operating Company have consulted their own legal, financial,
accounting, regulatory and tax advisors to the extent they have deemed appropriate. The Underwriters acknowledge and agree that the Underwriters
are not an agent of the Company or the Operating Company for any purpose under this Agreement including, for the avoidance of doubt,
for any purpose related to the representations and warranties of the Company and the Operating Company contained in Section&nbsp;1 of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;17. <U>Other
Provisions</U>. This Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company, the
Operating Company and the Underwriters, or any of them, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Each of the Company,
the Operating Company and the Underwriters hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right
to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Section&nbsp;18. <U>Counterparts
and Electronic Signatures.</U> This Agreement may be executed by any one or more of the parties hereto in any number of counterparts,
each of which shall be deemed to be an original, but all such respective counterparts shall together constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">The words &ldquo;execution,&rdquo;
signed,&rdquo; &ldquo;signature,&rdquo; and words of like import in this Agreement or in any instruments, agreements, certificates, legal
opinions, negative assurance letters or other documents entered into or delivered pursuant to or in connection with this Agreement or
the Indenture shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, without
limitation, &ldquo;pdf&rdquo;, &ldquo;tif&rdquo; or &ldquo;jpg&rdquo;) and other electronic signatures (including, without limitation,
DocuSign and AdobeSign). The use of electronic signatures and electronic records (including, without limitation, any contract or other
record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and
enforceability as a manually executed signature or use of a paper- based record-keeping system to the fullest extent permitted by applicable
law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records
Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the
Uniform Commercial Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">If the foregoing is in accordance with your
understanding of our agreement, please sign and return to the Company and the Operating Company a counterpart hereof, whereupon this
instrument, along with all counterparts, will become a binding agreement between the Underwriters, the Company and the Operating Company
in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthpeak Properties,&nbsp;Inc.</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Peter A.
    Scott</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Peter A. Scott</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Financial Officer</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthpeak OP, LLC</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: Healthpeak Properties,&nbsp;Inc., its
    Managing Member</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Peter A.
    Scott</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Peter A. Scott</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Financial Officer</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONFIRMED AND ACCEPTED, as of the date
    first above written:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Wells Fargo
    Securities, LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Carolyn Hurley</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Carolyn Hurley</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TD SECURITIES
    (USA) LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Luiz Lanfredi</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Luiz Lanfredi</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MIZUHO SECURITIES
    USA LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Robert Fahrbach</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Robert Fahrbach</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">BARCLAYS CAPITAL
    INC.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Meghan Maher</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Meghan Maher</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">RBC CAPITAL
    MARKETS, LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Scott G
    Primrose</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Scott G Primrose</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Authorized Signatory</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For themselves and as Representatives of the other Underwriters named
in Schedule&nbsp;A hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Name of Underwriter</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Principal<BR>
                                            Amount of&#8239;<BR>
                                            Notes&#8239;to be<BR>
                                            Purchased</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 86%; text-align: left">Wells Fargo Securities, LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">28,875,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">TD Securities (USA) LLC.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">28,875,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Mizuho Securities USA LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">28,875,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Barclays Capital Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">28,000,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">RBC Capital Markets, LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">28,000,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">BofA Securities,&nbsp;Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">23,625,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Credit Agricole Securities (USA) Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">23,625,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Credit Suisse Securities (USA) LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">23,625,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Goldman Sachs&nbsp;&amp; Co. LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">23,625,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">PNC Capital Markets LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">20,125,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Scotia Capital (USA) Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20,125,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Truist Securities,&nbsp;Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">20,125,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">M&amp;T Securities,&nbsp;Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">14,875,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Regions Securities LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">14,875,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Huntington Securities,&nbsp;Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: right">11,375,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">SMBC Nikko Securities America,&nbsp;Inc.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">11,375,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">350,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 36; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Schedule A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT&nbsp;B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Issuer Free Writing Prospectus constituting
part of Time of Sale Information</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Final Term Sheet dated May&nbsp;1, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">Exhibit B-1</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT&nbsp;C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Issuer Free Writing
Prospectus, dated May&nbsp;1, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Filed Pursuant to Rule&nbsp;433
under the Securities Act of 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Supplementing the Preliminary
Prospectus Supplement dated May&nbsp;1, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Registration Statement
Nos. 333-269718 and 333-269718-01</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><IMG SRC="tm2314172d4_ex1-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Healthpeak OP, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">guaranteed by</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Healthpeak Properties,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Final Term Sheet</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">5.250% Senior Notes due
2032</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">This term sheet relates
only to the securities described below and should be read together with Healthpeak OP, LLC&rsquo;s and Healthpeak Properties,&nbsp;Inc.&rsquo;s
preliminary prospectus supplement dated May&nbsp;1, 2023 (the &ldquo;Preliminary Prospectus Supplement&rdquo;), the accompanying prospectus
dated February&nbsp;10, 2023, and the documents incorporated by reference and deemed to be incorporated by reference therein. On January&nbsp;17,
2023, Healthpeak OP, LLC (as successor to Old Healthpeak (as defined in the Preliminary Prospectus Supplement)) issued $400,000,000 aggregate
principal amount of 5.250% Senior Notes due 2032 (the &ldquo;initial notes&rdquo;). The securities offered hereby (the &ldquo;additional
notes&rdquo;) will be issued as additional notes under the indenture pursuant to which the initial notes are outstanding. The initial
notes and the additional notes are collectively referred to as the notes in this pricing term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
<TD STYLE="vertical-align: top; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuer:</FONT></TD>
<TD STYLE="vertical-align: top; width: 60%">Healthpeak OP, LLC &nbsp; &nbsp; &nbsp;</TD>
</TR>
<TR>
<TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
<TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
<TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guarantor:</FONT></TD>
<TD STYLE="vertical-align: top">Healthpeak Properties,&nbsp;Inc. &nbsp; &nbsp; &nbsp;</TD>
</TR>
<TR>
<TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
<TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
<TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade Date:</FONT></TD>
<TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;1,
2023</FONT></TD>
</TR>
<TR>
<TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
<TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR>
<TD STYLE="vertical-align: top">Settlement Date: &nbsp; &nbsp; &nbsp;</TD>
<TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;10,
2023 (T+7)</FONT></TD>
</TR>
<TR>
<TD STYLE="vertical-align: top">&nbsp;</TD>
<TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Offered:</FONT></TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.250% Senior Notes due 2032</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Principal Amount Offered:</FONT></TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$350,000,000 (the additional notes
will be part of the same series of notes as the $400,000,000 aggregate principal amount of initial notes, and the outstanding principal
amount of the 5.250% Senior Notes due 2032 will be $750,000,000)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity Date:</FONT></TD>
<TD>December&nbsp;15, 2032 &nbsp; &nbsp; &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest Payment Dates:</FONT></TD>
<TD>June&nbsp;15 and December&nbsp;15, commencing June&nbsp;15, 2023 (short first coupon) &nbsp; &nbsp; &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Accrued Interest:</FONT></TD>
<TD>$5,767,708.33 of accrued interest from January&nbsp;17, 2023 up to, but not including, the date of delivery of the notes. &nbsp;
 &nbsp; &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benchmark Treasury:</FONT></TD>
<TD>3.500% due February&nbsp;15, 2033 &nbsp; &nbsp; &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Benchmark Treasury Price/Yield:</FONT></TD>
<TD>99-13 / 3.572% &nbsp; &nbsp; &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spread to Benchmark Treasury:</FONT></TD>
<TD>+190 basis points &nbsp; &nbsp; &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yield to Worst:</FONT></TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.472%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coupon:</FONT></TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.250% per year</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price to Public:</FONT></TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98.356% of the principal amount,
plus Aggregate Accrued Interest </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Exhibit C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optional Redemption
    Provisions:</FONT></TD>
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Make-Whole Call:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to September&nbsp;15,
    2032 (the &ldquo;Par Call Date&rdquo;), +30 basis points</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Par Call:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On and after the Par Call Date,
    at par</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CUSIP / ISIN:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42250P AE3 / US42250PAE34&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Net Proceeds: </FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Approximately $347,738,708.33,
including $5,767,708.33 of accrued interest, after deducting underwriting discounts but before deducting estimated offering expenses
payable by the Issuer.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Issuer intends to use the
    net proceeds from the offering to repay borrowings outstanding under its commercial paper program and for general corporate purposes,
    which may include repaying or repurchasing other indebtedness, working capital, acquisitions, development and redevelopment activities,
    and capital expenditures.&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Book-Running Managers:</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-indent: -3pt; background-color: white">Wells Fargo
    Securities, LLC&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">TD Securities (USA) LLC&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Mizuho Securities USA LLC&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Barclays Capital Inc.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">RBC Capital Markets, LLC&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">BofA Securities,&nbsp;Inc.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Credit Agricole Securities (USA) Inc.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Credit Suisse Securities (USA) LLC&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Goldman Sachs&nbsp;&amp; Co. LLC&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Managers:</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;PNC Capital Markets LLC&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Scotia Capital (USA) Inc.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Truist Securities,&nbsp;Inc.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">M&amp;T Securities,&nbsp;Inc.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Regions Securities LLC&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Huntington Securities,&nbsp;Inc.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">SMBC Nikko Securities America,&nbsp;Inc.&nbsp;</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>The Issuer expects that delivery of the
additional notes will be made to investors on or about the settlement date specified above, which will be the seventh business day following
the date of this term sheet. Under rules&nbsp;of the Securities and Exchange Commission, trades in the secondary market are required
to settle in two business days, unless the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade
the notes offered hereby on the date of this term sheet or the next succeeding two business days will be required, by virtue of the fact
that the notes initially settle in T+7, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed
settlement. Purchasers who wish to trade the notes on the date of this term sheet or the next succeeding two business days should consult
their advisors.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>The Issuer and the Guarantor have filed
a registration statement (including a preliminary prospectus supplement and a prospectus) with the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus
supplement and prospectus in that registration statement and other documents the Issuer and the Guarantor have filed with the SEC for
more complete information about the Issuer, the Guarantor and this offering. You may get these documents for free by visiting EDGAR on
the SEC&rsquo;s website at www.sec.gov. Alternatively, the Issuer, the Guarantor, any underwriter or any dealer participating in the
offering will arrange to send you the prospectus supplement and prospectus if you request it by calling Wells Fargo Securities, LLC toll-free
at (800) 645-3751, TD Securities (USA) LLC toll-free at (855) 495-9846, Mizuho Securities USA LLC toll-free at (866) 271-7403, Barclays
Capital Inc. toll-free at (888) 603-5847 or RBC Capital Markets, LLC toll-free at (866) 375-6829.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>No PRIIPs or UK PRIIPs KID &ndash; No
PRIIPs or UK PRIIPs key information document (KID)&nbsp;has been prepared as not available to retail in EEA or UK.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Exhibit C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm2314172d4_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit&#8239;99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2314172d4_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Healthpeak
Prices Add-On Offering of $</B></FONT><B>350 Million of 5.250% Senior Unsecured Notes due 2032</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DENVER, May&nbsp;1, 2023 /PRNewswire/ -- Healthpeak Properties,&nbsp;Inc.
(&ldquo;Healthpeak&rdquo;) (NYSE: PEAK) announced today that its operating company, Healthpeak OP, LLC (the &ldquo;operating company&rdquo;),
has priced a public offering of $350 million aggregate principal amount of additional 5.250% senior unsecured notes due 2032 (the &ldquo;notes&rdquo;).
The notes will be senior unsecured obligations of the operating company and will be fully and unconditionally guaranteed by Healthpeak.
The notes will be issued as additional notes under the indenture for Healthpeak&rsquo;s prior issuance of $400 million of 5.250% senior
unsecured notes due 2032 (the &ldquo;initial notes&rdquo;). The notes will be treated as a single series of securities with the initial
notes, will have the same CUSIP number as the initial notes and will trade interchangeably with the initial notes upon settlement. The
price to investors was 98.356% of the principal amount of the notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The estimated net proceeds of the offering are expected to be approximately
$347.7 million, including approximately $5.8 million of accrued interest, after deducting the underwriting discount but before deducting
fees and expenses payable by the operating company. The operating company intends to use the net proceeds from the offering to repay borrowings
outstanding under its commercial paper program and for general corporate purposes, which may include repaying or repurchasing other indebtedness,
working capital, acquisitions, development and redevelopment activities, and capital expenditures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The offering is expected to close on May&nbsp;10, 2023, subject to
the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wells Fargo Securities, TD Securities, Mizuho, Barclays and RBC Capital
Markets are acting as joint book-running managers for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The offering is being made pursuant to an effective shelf registration
statement and prospectus and a related preliminary prospectus supplement filed with the Securities and Exchange Commission. This press
release shall not constitute an offer to sell or the solicitation of any offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Copies of the prospectus supplement and related prospectus for the
offering, when available, can be obtained from: (i)&nbsp;Wells Fargo Securities, LLC at 608 2nd Avenue South, Suite&nbsp;1000, Minneapolis,
Minnesota 55402, Attention: WFS Customer Service, or by calling: 1-800-645-3751, or by emailing: wfscustomerservice@wellsfargo.com, (ii)&nbsp;TD
Securities (USA) LLC at 1 Vanderbilt Avenue, 11th Floor, New York, NY 10017, Attention: Transaction Advisory Group, or by calling: 1-855-495-9846,
(iii)&nbsp;Mizuho Securities USA LLC at 1271 Avenue of the Americas, New York, New York 10020, Attention: Debt Capital Markets, or by
calling: 1-866-271-7403, (iv)&nbsp;Barclays Capital Inc. at 745 Seventh Avenue, New York, New York 10019, Attention: Syndicate Registration,
or by calling: 1-888-603-5847 or (v)&nbsp;RBC Capital Markets, LLC at 200 Vesey Street, 8th Floor, New York, New York 10281, Attention:
DCM Transaction Management, or by calling: 1-866-375-6829.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Healthpeak</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Healthpeak Properties,&nbsp;Inc. is a fully integrated real estate
investment trust (REIT) and S&amp;P 500 company. Healthpeak owns, operates and develops high-quality real estate focused on the aging
population and the desire for improved health.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release contains forward-looking statements within the meaning
of federal securities laws and regulations. These forward-looking statements are identified by their use of terms and phrases such as
 &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;will,&rdquo; &ldquo;project,&rdquo; &ldquo;anticipate,&rdquo;
 &ldquo;position,&rdquo; and other similar terms and phrases, including references to assumptions and forecasts of future results. Forward-looking
statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors which may cause
the actual results to differ materially from those anticipated at the time the forward-looking statements are made. These risks include
our ability to complete the offering in a timely fashion or at all, that the proceeds from the offering may not be deployed as anticipated;
and those risks and uncertainties associated with Healthpeak&rsquo;s business described in its Annual Report on Form&nbsp;10-K for the
fiscal year ended December&nbsp;31, 2022, its Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2023, and its subsequent
filings with the Securities and Exchange Commission. Although Healthpeak believes the expectations reflected in such forward-looking statements
are based upon reasonable assumptions, Healthpeak can give no assurance that the expectations will be attained or that any deviation will
not be material. All information in this release is as of the date of this release, and Healthpeak undertakes no obligation to update
any forward-looking statement to conform the statement to actual results or changes in its expectations, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Andrew Johns, CFA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Senior Vice President &ndash; Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">720-428-5400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hcp-20230501.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaKPybOdzZR+2YkxtmB+benqvyQggWMduyGa1K+GEScB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:hcp="http://hcpi.com/20230501" elementFormDefault="qualified" targetNamespace="http://hcpi.com/20230501">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://hcpi.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="hcp-20230501_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="hcp-20230501_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hcp-20230501_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hcp-20230501_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://hcpi.com/role/Cover" xlink:href="hcp-20230501.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://hcpi.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2314172d4_ex1-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2314172d4_ex1-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !1 /@# 2(  A$! Q$!_\0
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M<[!(0!], 4 =H)HV5F#J0IPQ!Z?6HHM0LYY/+ANH9'_NI(":Y'1_^1:\3_\
M7[<_R%5?AWIU@+#3[E/#9L[@6B'[:W_+0E1DCZ]: .HUVPT36XH]-U?RI 76
M5(6E*$L.AX(-:Z(L<:H@PJ@ #VKSK5]/M+#Q1?7GB#3GN+*ZEC:VU!&.;;"J
MNPX^Z-P)R/6O1EP4!4Y&.#0 ZBBB@ HHHH **** "BBB@ HHHH *\UU[X0V>
MO:[>:I)K%_"]R^\QQL-J\8XX]J]*HH \A?X.3:0IU#1->OCJ-O\ O(%E(*L1
MV/'?I5Z#3M)^).FM]LB;3O$E@0DLL)V21OV/NIQ7J%<3XK\.W,-_'XG\/CR]
M6MAB:(?=NHNZL/7T- &/%X5T?P-:3>(_$=Y)J^IKQ'+<<\]E1?7WK.7X?:EX
M\)UWQ#J5U8O-_P >]K 0!%'VSGN:V=$TV_\ &NKQ>(?$-LUO8VO%CI[=-W>1
MQW/85Z*  , 8 H \HB^!UC%,D@UW4B48-@LO./PKU."(0P1Q DA%"Y/? Q4M
M% &3J^D?VG>Z7<"79]AN#/C&=WRE<?K4^L6']J:/=6(?RS/&4W8SC-7Z* .>
MB\.FUU'2[VWGV2VML+6?Y>)T &,^A!!Q]35>ZT#5+75+F]T'4(+7[9AKB&XA
M,B%P,;UP00<8'IP.*ZFB@#GM,\."RT>]MY+EI[N^+/<W+#EW*[<X[   8]JU
M-*LO[-TJULB^_P B)8]V,9P.M7:* .4AT+7K&]O)-/U6T2VN;DSF.2V+,"0H
M(SN']VM6XT@W.LV6H22 BWMY863;]_?MY_\ '?UK6HH Q]#T<Z-936@G:: 3
M.\ 8<QHW.WW );'L<4_0M).C6$EL9?,W3RS;L8^^Y;'ZUJT4 8-GH!M--U2T
M^T;OMTTDN[;]W>.E5_#^D:[I$-I:7&J6L]E;Q"((ML5<@# YW?TKIJ* .1U7
MPUK-_/>0PZRHTR]96DAFAWO'@ $(V1@'&>0:ZN.,1QI&.B@ ?A3Z* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2314172d4_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2314172d4_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" != 2P# 2(  A$! Q$!_\0
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M^*&HZ/XIM_"GA728]5UJ0*TF_)2/=R%P",G;\Q8D  @\\XQCJWQW,C$>'].
MSG;YEO\ _': -KX,^-M1\3Z7J.F:V6?5-*D5))6 !D5L@9]6!0@GZ5B_#O\
MY+[XX_W'_P#1B5C_  %-VWC[Q2;]0EZ8\SJI! D\T[L8)'6M?X>?\E\\<?[C
M_P#HQ* .+^(GA'Q#IOC70H+WQ(UW-J-[BSD(;_12TH (R>Q(Z>E>H>$OA[XP
MT/Q-9ZCJOC*34;*'?YEJ0_[S<C*.I[$@_A6-\8?^2C> /^O^/_T<E>TY&>M
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MKC_M 1>(EL'.E! #<9&/N8Z=>M>KW\;2Z==1H,N\3JH]20:E)YI=X/3J1D4
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MC,&D9L[?+/\ >]:Z76?^$AAGM+K18K.X50RW-I<.8]V<$,K@'!&#QC!SVQ0
MGA(6QT**2QUZ;6K.1V>"YFE$K!#T0L.6*G(RWS=CTK>QS7+^#=!O=(35+O4$
MM8+G4[YKM[6S)\F'Y54 9 W,=N6; R3TKJ: "BBB@ HHHH **** "BBB@ HH
MHH **** $VT8I:* $(]\5YEXF\)7_AG7'\9^#HO](/.I:8IPEVG5BH_O]_\
M//IU)B@#S;6?BK92^';*3PO%_:.MZH3':6(^_&_1C(O8+SUXXZXK7\!^#7\.
M6D][JLXOO$6H-YE_>MR2>T:GLHX^OMP!L6'A'0=,UZ[UNRTR"'4KL8FG4')]
M<#.%SWQC/>MD(%.1]?QH  N#G-*12T4 (!01FEHH 3'O1BEHH 3;[T 4M% #
M=M.%%% "8YS2;3ZTZB@!NWFEVTM% "8HQ2T4 )BDVTZB@!,4M%% !1110 44
544 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140419583311296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  01,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-08895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Healthpeak
Properties, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000765880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0091377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4600 South Syracuse Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">428-5050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $1.00 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PEAK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>tm2314172d4_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hcp-20230501.xsd" xlink:type="simple"/>
    <context id="From2023-05-01to2023-05-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000765880</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-01to2023-05-01">0000765880</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-01to2023-05-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-05-01to2023-05-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-05-01to2023-05-01">2023-05-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-05-01to2023-05-01">Healthpeak Properties, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-01to2023-05-01">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-05-01to2023-05-01">001-08895</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-01to2023-05-01">33-0091377</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-01to2023-05-01">4600 South Syracuse Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-05-01to2023-05-01">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-01to2023-05-01">Denver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-05-01to2023-05-01">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-01to2023-05-01">80237</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-05-01to2023-05-01">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-01to2023-05-01">428-5050</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-05-01to2023-05-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-05-01to2023-05-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-05-01to2023-05-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-05-01to2023-05-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-05-01to2023-05-01">Common stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-01to2023-05-01">PEAK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-01to2023-05-01">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-01to2023-05-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M8,"ZDHH6JEM]>&5;\&@7G\E(!,*(9,4>L;R5X%$E#ZU2Q^.7;<"GC7JJX#+
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "TA:)6JL0B%C,!   B @  #P
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M2P$"% ,4    " "TA:)6&?G84^\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "TA:)6F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( +2%HE;>V!@X8 0  !L1   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "TA:)6GZ ;\+$"  #B#
M#0              @ &D#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +2%
MHE:7BKL<P    !,"   +              "  8 /  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( +2%HE:JQ"(6,P$  "("   /              "  6D0  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "TA:)6)!Z;HJT   #X 0  &@
M            @ ')$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " "TA:)699!YDAD!  #/ P  $P              @ &N$@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #X$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2314172d4_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hcpi.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2314172d4_8k.htm">tm2314172d4_8k.htm</File>
    <File>hcp-20230501.xsd</File>
    <File>hcp-20230501_lab.xml</File>
    <File>hcp-20230501_pre.xml</File>
    <File>tm2314172d4_ex1-1.htm</File>
    <File>tm2314172d4_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2314172d4_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2314172d4_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hcp-20230501_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hcp-20230501_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hcp-20230501.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hcp",
   "nsuri": "http://hcpi.com/20230501",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2314172d4_8k.htm",
      "contextRef": "From2023-05-01to2023-05-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://hcpi.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2314172d4_8k.htm",
      "contextRef": "From2023-05-01to2023-05-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://hcpi.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-23-055056-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-055056-xbrl.zip
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MU5[0VVO HW!+*;4>Y$@L1HSL",9#4;+^J8=A844WJ.<=R4O7=VG7U- J*ET
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MNH#AZ20O+9L;!<XX()&+-_/_%@\//B.:G>ZO8*9GT5BA]W="97M<1T6;L3B
MJA(>(],':'F+*8[K<AM.H@^%;$SW.*15[_(:BD*C@-+42^Q>H?(5QCRQ>,?6
MANV$0TK?,^!1JA0@L\H"%(A<8L-?=VBA5?.X*>N]5H]F##_&(F2%30^ /[8K
M (@T@R7-NKC8N'=YAHVR9POBE4^?X')A64^!#D=&EK:H@<; QJNF"%I;N%Q1
M#C9V-A5]N#)LGR/'.F,[RUCJ"H9GOIRNA4R\.&3F?+AKZA"_90F&5V4J.D.D
M*[-H1_WO-NA%# 7/L'K$Y,]D'B&)+B(E5-IA'$.IMM-L I[AL3WSBZ2T2X8;
M4JQE./ 3;-EHDF1B:U_$5F8%7>7\2/N#:;Z5U-<3#0.5KK.Z>QV%)/%K)%\,
M.* $F[739R6W2ZN7W>,Q)&:%Q)+EPGA"#-(DTH58#2A@752HFH\C[U=P!CI!
MD>';,:/^#&;#Q)^/T%&?PP(BS"Q\(]%'),=+!2(8+D(1-"E5[3""B!(+DT?E
M0\$A(GTQ* 4^_^9.=ZARJZR@I%2JWMKVY HDPI;LW,@ 1MPBW!NW*3U0?-=2
M]H"?I$3.S54R[*:2FKS6YXE+P?? I@1W&GK+HELR/6A(],&<8Z8*<3*-S[@4
MPZ$Y"U.3>AI<0P74I3!M].!AR0DKXL)L^7X.%J#@=D)@MU9PZJ$<K4XC=Y52
M"F!'0/@(3%*)\H*78?% 99+63&"<.@)9R6<RPN@,-O&,4%T(J:26]-9V9O5I
M?F6T).7&5[*=:,^@)G67=J8@I'8R&6NHMO#]GK/R4:FP\$K2-I9L4[A@GY2:
MZ2)T,-=L?$_N:)UQHV!!I;,30^KG/(&'*@=;!.%[$"VHK37QS3_E6HE6UBFU
MO8E2IE0Z*C4E0BFV+1)+YP/EA1)?&'74=*30)AQ^UM6:\)DN'MC;.F=T4%P%
M^9U"G +C&I+34-GO=@L,,I+5V?MM%F$<+(Z;:03*1-&1)?+GFHB0GCX;,N2L
M!L7 &&JH_ZTQ67;T1N[\6-[(EX_>R#5@>C;7LYD9\3Z-/8M<Q$J*X#P+AU&T
M)7^%XIV1H()I1M65:Y%6%[*UKQT]]K/F^*AY/@MU$#/B< 9=1&H:C&B0L-K6
M2 A9.H U9BS7B2A]7[3QVBUF<FJH9X-QE]W:?O/;3G0A-H;L]6O+)6&LVJ_7
M'$I=4K&!(7>?,K"QP14Q:V.UB5Q(B\9OU]WC&<09Y1Y)=IR8F;%IOM&M05<]
M(XC4S;B8E'9V!_E6^76FST@^5F)91PU@1091]JV83:LA01:!I+E Y06S:=S\
MYPFJL;!ALTDSB8"\.(230X[WW#&>T5$X2N!6@RS#.0<:JXIKW.?J"\[1H;BZ
M :QBXFJC8I.AW$2K?IA<8"$3,"J<(B6MPQFVP!<L/)4".*H.(W=SA0$R2%1H
MQYRM7H7B<B4KNJ:4-DY<J'N/*3^T.73-P]9>\N2<+KNE10M4NR>O#DST*YZC
MH/LQZO>N?XYT&G7]' 7+CU&H P*$4RJV.+H ZO8$7XF;7:4&"%_2N' C:F$8
M)BI-9PMSRH6N:'N$3HOXBF067(G*HB:=P<EIX^JMU/4P&',K075AS(:B@ALF
MJ(?)MRVU_2UY]:8.VS9!3,.I/8%-(PAU[\:<@&%;4+EDM6V?M,%G,P2BVI$U
MNCW6*H.L[;9*9 61SGH)#JKT>\\<?Y@W$8'*HRR7V@*'V4.E%8M83N(L(0^3
M*^'K\ARX[S>S1?2),!NG4:%!0I%$9AEY86B'1_$ -H21?:S*0]A9]OE6M:LV
M";;"KZ%2%3,6\UCYXP)H0WU332B KE29PQF,I1!_/4&\,[<H:=*J3WSK@/22
MW-YXUIC".CJI=G\L)]7.]J.7:@T8F,7!3E'PDU7P1>)?32 D+W(!V2A4+DFZ
M [$#:O_#83L=2DOLW/G:KZHNQ9.5Y4#)>2J^$.8AB;$BQ$IB*44='9-XK7F_
M49LU"-$L^!CR%CZ:P)0;3,I7:-NQ8AR/W/LRMA61@&K=.!9O%#=:BX8J=D:[
MI=ZM=D>G?3L[%-:?WN\U'I\/1"DI89XE-E[(*>4I0U!\,1 W!)98E>X"4QI*
M90P/!U3I6:%B'HBIEE2Z> <M >JUAVR?RF[R:9)Q=A:5CJ#43!&H%CT-4Y$C
M\?=H@D))93\-2HY"6G5#,6&K#747*1MHMN;3,@X,!UIV4\V3+!71L>.S'%L[
M!*=*EX;5;6VBN, SA5^;G*92RD"DA64=A\ZJ.R!KEC*G*'&*SMTXNL@+W[N;
M@"24<R&&&)TPLZ8V;>"U3@!<R$F/M]^+LS_RN1HPM?E-I %=144-H0ZLYQEW
MF>,3JPJTF#2<V&D3WU'J!66$#+Z7CUWBYD)#5JA-I^ KX[)<]0QB=I8<PBAK
M.7E2.N+N8.,8-E^PXBFDDW-3QS"XSBD$,KG^,5QC/?!:@MII2*6*B4SJ%/47
M7I33WN*O;N0XF>8FE% (:CXU=#I++O ^%VQ;Q:D]6;H#P\\BT[K.2CK$7!Z3
M>>2#P_A2Q$^^% D5='DZ(-E9,&+N6N'\^F2<2BM=BV6M'I=:/=U>5&J%O]<[
M.3]0>K/([3C2;*+5JB6>7/,M,*F5S?I52O0O@O>HR?TN(5!K@RE1B8,%<,,[
M]B_P:-YP$O9:XXI?:]4M;?Q++%Y/*U^4B/^=8:36/K0D*B7<$;>R4M?PN.E<
M.ROWDXIM#8_F ^,VI]X8J7:_P*Q?;,3^YK\F<&>QF:ZC\+VVV1-[6>9,T/#6
M/5B*L?V5NJ09!4-6%7G*)$,D-,(HKQ_:%E6-0<H==?'Z"2@0J$24BOF-3+'T
MT'[P5#]85;1N$-8W9F;&Q00Q:?QH53M[T9.=?4U!^*R=_9']E1,H?(J[OLDN
M(%V"14@-,:)K,<./,QJ@^(E$.73:;]B>=B=\8*J2%K;'(1@<0E1&+;ZN/FH-
M_/ \B<=P3BFE CCAY_$X&4K9"'5ZY0MT0RI] 4A-TH2XA4>BL++))T^OQQ36
M9(C(U(A(;6P U2/)J1T:)RDQ#0\$-#V?S91#TP-1ES&@EXU:WWE.X\X>]?>%
M?X::&<#>&=8P=C:-;.U!S*><FTV$5OD:"@Z,=&$4$S5V6G+,Q=,-!Q5<ECR7
M$+#'WF6?Y"7F3@^I 0L0+"PLU7T3T(WQ=% HRW09KJBCF]6(I%2*;QI?Q)3O
M*M5.O*BS3/+[QGFSM9]UD-:8X71T2.[]8 [)G4>'Y#K(,Z=G)(,B:'%V1?&5
M*' %$5X!I@9;;1\*U=3'*\4"(\3(>]"08N.F%!M?68I10=;(;HX4&);$MUH]
M+TBFZ=+B?.R;E%;'[#Y,SJ56K)%X[W=9+MWHW1,^;W:R0Z>&MY4=\E^KPT1@
M-5L*;K/7DM-A?J%'U@-3<U.]EC#+_$:[>S6[++U2(LX2JD%-I@[F+.[A\,(Z
M^M(TW=+LE92:%GTF=%SW88#UYV327$><;]Z<>M#OX0.W@!*":*2:P:"A@GX,
M"]YU),#F1JGR;5V7]QYDV8PP7I"PT5-I>F[O;#_Y1]COV?F&=D-<[4W!SGWB
MD*MB/:P!]G#%#QK+L;Z]Y]&(:2(:723HF8/?->H\DJ\%4]OO(;\;)@BG(P?8
M=& !<8>+'FL$).9>C,@4&_;2F>DZ93W"]+! ^5N,&2X83/(5GM676?% N!Y6
M (Y8R-8)ECAQ@TA0+&@J_.*6;I%TDN96%\)Q 4M.18%..QZU'J%$L+,+3  J
MG?.EHPL"LL5MC26L8Z,"P^IH!E:?5WT9^[VV=;0[0-DD:Q.@, 39(D$<]1IT
MJFC4:0;$6%QEH!J +AML^YXSV^3U81^U(*S3^^Q21MIR:1K52B*-&SJM9>OP
MUEAYOY87V<I*9>BL?N^KK:'L&4>RK62)_P;8H5:H0!B=D;2FY+]"*4X"":Q!
ML"[C-'W"QG))&Q<+>F(1JEM$1O1[JE68Y3!PW4IN3S$3=+%Z ]=O<CU%P8_K
M*+)V_CU7:*-276 "(V@]J(QAS-R$$2S8.Y.S;RK=ZB?+C4"U%WLOKQOEUR@Q
M%N).L2Z!57O$5#5FX4HP"=$EX5]2*A$:#57T+>;Z:BF(US"8TC+6X& 27^*X
MO$%3V(B4D+! %09SYJDPJ])*AY85#[P+SI&'Y\_MR$/($7;RJ+?W>*\,!$DM
M4O'^\,N!V^)-*W<,=9+/*DYF54FJT3?ROAJ(&#"BTE(#6DQB#!_G-K1&I$P.
MXJH<K$2])$;\UB'/E)IE!6,N]%1H,5'&QP_=67-6SD'L3!#_$>V?B'?23IK7
M^6QR@ZKUG "5SJTPODE6.$O&[F.QS6'H>S!-5L);_%CTO-'?'$*6Y#99W+$Z
M/$27(#26F8R*(^&6;"H:51#M&'?%-.K4+D[GY^K8F-PRQ.0X$NMC@[( IH5^
M A^44#@>F$ 7Z#<T<\0!$';40&LWM ]9&5O1L3<8@RMT2&QW>V=;/>!K1LGT
M_X#5&>63.LE]_4>_9]WL4I\ZFK1+E@&#>:E/!G(7702?A79PZ%1^VDA \L<R
M*6\=DV,7\ITE618-K7*,"G^D8UP"+1_30Q+3^9&U80-$Q. -7J-0RR#<$'[K
MUW\XZT[HY%=:JO6571U]CD]_,)_C[J//\>Y5(\OC^!$E2K_W(2*.R*ZGR[*!
M?V[)]H6Y.*AR.'RAW5?$F=_FO%NMVMF>_1;'4^7-,W9488$GZ"%A;C0B'."E
M2O<XM;$)C&?-*"#;K@+"EB.L!G 6M1C<-9ZJ+R7QTAJPW>U#\I2ZZ2X*KI:B
M<VSH:?3C&56P. V[0",QWC!5?&20J"C;@P#-J(IGI)",? !&&T +*?N14A$
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M>#$0,JN1AXBYYIBPUT52Q+IC)_O2)F ^H5,1E23MK$"+GIT4A)2EDADE6]"
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M(L1'N<DJ%2<IB[_<;=/C6TR4J 9LV?)J81@=+@(9\8!0+&[0MAC>;76K4+J
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M@:,XST%$I )6KOQTPRB-)I+8/,2)<#D OY$<;A=QFD\Y)3.[R%/J-1[I1:<
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M=Z-!?Q0-!]WN)L/_+4-%_XB]#RGFD%VA^/_?SQC_NX9_A_X4*?QM$OT)T[\
M4$L! A0#%     @ M(6B5MA\7RXV P  Y@L  !               ( !
M &AC<"TR,#(S,#4P,2YX<V102P$"% ,4    " "TA:)6;/*C&O\*  !LAP
M%               @ %D P  :&-P+3(P,C,P-3 Q7VQA8BYX;6Q02P$"% ,4
M    " "TA:)6D@@T&T\'  "X6   %               @ &5#@  :&-P+3(P
M,C,P-3 Q7W!R92YX;6Q02P$"% ,4    " "TA:)6P?Q9;,D4  ">:P  $@
M            @ $6%@  =&TR,S$T,3<R9#1?.&LN:'1M4$L! A0#%     @
MM(6B5G%"S5_ZA   \G<# !4              ( !#RL  '1M,C,Q-#$W,F0T
M7V5X,2TQ+FAT;5!+ 0(4 Q0    ( +2%HE:*^&2!3 L  ,DD   6
M      "  3RP  !T;3(S,30Q-S)D-%]E>#DY+3$N:'1M4$L%!@     &  8
*B0$  +R[      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
